GLP-1 Market
LLY $1142.85 ▼ -0.6% NVO $37.32 ▼ -0.2% PFE $27.80 ▼ -1.1% VKTX $29.94 ▼ -1.9% KLRA $10.39 ▼ -5.8% GPCR $27.67 ▼ -4.5% RHHBY $52.25 ▼ -0.2%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Omeprazole

Company
Nantes University Hospital
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
47 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

47 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 5, 2026

Find a Clinical Trial Near Me

See recruiting studies for Omeprazole and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02373280

    The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

    Not yet reported Seoul National University Bundang Hospital 600 participants Est. completion 2027-12 1 site
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Recruiting NCT NCT03365609

    A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

    Not yet reported Ying HUANG 1440 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Recruiting NCT NCT03647852

    Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

    Not yet reported Children's Hospital of Fudan University 150 participants Est. completion 2026-10-30 3 sites Stand-alone
    Other conditions: Henoch-Schönlein Purpura
    View official trial listing →
  • Recruiting NCT NCT03866668

    A Study of Esomeprazole in Children With Autism

    Not yet reported Stanford University 25 participants Est. completion 2028-12 1 site
    Other conditions: Autism, Autism Spectrum Disorder
    View official trial listing →
  • Recruiting NCT NCT03947385

    Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

    Not yet reported, Not yet reported IDEAYA Biosciences 336 participants Est. completion 2027-06-15 15 sites Stand-alone
    Other conditions: Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer, Other Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT04337580

    Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer

    Not yet reported Wake Forest University Health Sciences 50 participants Est. completion 2028-03 2 sites Stand-alone
    Other conditions: Prostate Cancer, Refractory Cancer, Castration Resistant Prostatic Cancer
    View official trial listing →
  • Recruiting NCT NCT04394663

    High Dose Oral Omeprazole in High Risk UGIB

    Not yet reported King Chulalongkorn Memorial Hospital 128 participants Est. completion 2025-12-31 2 sites Stand-alone
    Other conditions: GI Bleeding
    View official trial listing →
  • Recruiting NCT NCT04448028

    Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 476 participants Est. completion 2028-02 1 site
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Recruiting NCT NCT05176483

    Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    Not yet reported Exelixis 1394 participants Est. completion 2030-06-28 122 sites Stand-alone
    Other conditions: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Clear Cell Renal Cell Carcinoma (ccRCC), Non-Clear Cell Renal Cell Carcinoma (nccRCC), Drug-Drug Interaction (DDI)
    View official trial listing →
  • Recruiting NCT NCT05320796

    The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

    Not yet reported Prof Urs Zingg 50 participants Est. completion 2027-12-31 1 site
    Other conditions: Obesity, Gastric Reflux, Ulcer, Gastric
    View official trial listing →
  • Recruiting NCT NCT05517928

    A Study to Evaluate the Impact of Lactobacillus Rhamnosus GG on Proton Pump Inhibitor-Induced Gut Dysbiosis

    Not yet reported Mayo Clinic 30 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Recruiting NCT NCT05582174

    PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers

    Not yet reported Chinese University of Hong Kong 594 participants Est. completion 2028-07-03 8 sites
    Other conditions: Upper GI Bleeding, Proton Pump Inhibitors
    View official trial listing →
  • Recruiting NCT NCT05646862

    A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

    Not yet reported Hoffmann-La Roche 420 participants Est. completion 2029-03-30 210 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05799105

    OPEN Versus InTact Capsule Proton Pump Inhibitors for the Treatment of Marginal Ulcers

    Not yet reported Stephen Firkins 122 participants Est. completion 2027-03-23 1 site Stand-alone
    Other conditions: Marginal Ulcer
    View official trial listing →
  • Recruiting NCT NCT05874570

    Doxycycline for Helicobacter Pylori Rescue Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 368 participants Est. completion 2025-10-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT06114836

    GERD Infant Feeding Therapeutics Trial (GIFT Trial)

    Not yet reported Nationwide Children's Hospital 369 participants Est. completion 2028-11-01 1 site
    Other conditions: GERD in Infants
    View official trial listing →
  • Recruiting NCT NCT06120803

    Esomeprazole and Radiation Induced Esophagitis

    Not yet reported Rush University Medical Center 48 participants Est. completion 2028-06-30 1 site
    Other conditions: Radiation Esophagitis, Locally Advanced Lung Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06150898

    Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

    Not yet reported Jules Bordet Institute 112 participants Est. completion 2027-10 1 site Stand-alone
    Other conditions: Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06255886

    Treatment of Gastroesophageal Reflux Disease in Infants

    Not yet reported Odense University Hospital 96 participants Est. completion 2026-12-26 3 sites
    Other conditions: Gastroesophageal Reflux, Infant, Newborn, Diseases
    View official trial listing →
  • Recruiting NCT NCT06348420

    Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment

    Not yet reported Qilu Hospital of Shandong University 74 participants Est. completion 2028-12-30 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Recruiting NCT NCT06383338

    A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.

    Not yet reported Murdoch Childrens Research Institute 10 participants Est. completion 2026-11 1 site
    Other conditions: Hodgkin Lymphoma, Non Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT06393868

    Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

    Not yet reported Ottawa Hospital Research Institute 360 participants Est. completion 2028-03 7 sites Stand-alone
    Other conditions: Venous Thromboembolism, Gastro Intestinal Bleeding, Blood Clot
    View official trial listing →
  • Recruiting NCT NCT06510010

    Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer

    Not yet reported Sixth Affiliated Hospital, Sun Yat-sen University 198 participants Est. completion 2027-07-31 1 site Stand-alone
    Other conditions: Chemotherapy Effect
    View official trial listing →
  • Recruiting NCT NCT06562907

    Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

    Not yet reported Gilead Sciences 134 participants Est. completion 2026-11 3 sites Stand-alone
    Other conditions: Weight Management
    View official trial listing →
  • Recruiting NCT NCT06690164

    Study on the Effect of Atorvastatin Co-administered With Omeprazole on Statin Lactone

    Not yet reported National University Hospital, Singapore 78 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Metabolite
    View official trial listing →
  • Recruiting NCT NCT06693960

    Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

    Not yet reported Washington State University 16 participants Est. completion 2027-01-31 1 site Stand-alone
    Other conditions: Interaction
    View official trial listing →
  • Recruiting NCT NCT06733675

    Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

    Not yet reported Basilea Pharmaceutica 96 participants Est. completion 2026-12-30 1 site
    Other conditions: Healthy Volunteer, Pharmacokinetics, Safety, Drug-Drug Interaction (DDI), FDC
    View official trial listing →
  • Recruiting NCT NCT06850480

    A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis

    Not yet reported Livzon Pharmaceutical Group Inc. 356 participants Est. completion 2025-04-30 1 site
    Other conditions: Reflux Esophagitis (RE)
    View official trial listing →
  • Recruiting NCT NCT06861478

    PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver Disease

    Not yet reported Universidad Autonoma de Nuevo Leon 60 participants Est. completion 2026-09-20 1 site Stand-alone
    Other conditions: Morbidity
    View official trial listing →
  • Recruiting NCT NCT06917963

    Study of Treatment With Intensified Omeprazole Treatment to Prevent High Output Stoma 1

    Not yet reported Medical University of Gdansk 80 participants Est. completion 2027-07 2 sites Stand-alone
    Other conditions: Stoma - Ileostomy, High Output Stoma, Colon Cancer, IBD (Inflammatory Bowel Disease), Ileus, Omeprazole
    View official trial listing →
  • Recruiting NCT NCT06953986

    A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

    Not yet reported Asian Institute of Gastroenterology, India 414 participants Est. completion 2027-12-12 1 site
    Other conditions: GERD
    View official trial listing →
  • Recruiting NCT NCT06955520

    Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

    Not yet reported Asian Institute of Gastroenterology, India 300 participants Est. completion 2028-12-25 1 site
    Other conditions: GERD
    View official trial listing →
  • Recruiting NCT NCT06959368

    Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication

    Not yet reported Asian Institute of Gastroenterology, India 484 participants Est. completion 2026-03-25 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Recruiting NCT NCT06999577

    The Mechanism Versus PPI Trial

    Not yet reported University of California, San Diego 160 participants Est. completion 2029-07-01 1 site
    Other conditions: Laryngopharyngeal Reflux, Cough, Throat Clearing, Dysphonia, Reflux
    View official trial listing →
  • Recruiting NCT NCT07014930

    Identification of New Tools for Predicting Natural Metabolic Performance of the Liver

    Not yet reported Caroline Samer 40 participants Est. completion 2026-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07037888

    Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy

    Not yet reported Henry Ford Health System 100 participants Est. completion 2026-12 1 site
    Other conditions: Femoracetabular Impingement, Hip Arthroscopy
    View official trial listing →
  • Recruiting NCT NCT07139366

    Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

    Not yet reported Yongquan Shi 1248 participants Est. completion 2026-09 1 site
    Other conditions: Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
    View official trial listing →
  • Recruiting NCT NCT07156201

    A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

    Not yet reported Actio Biosciences, Inc. 92 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: KCNT1-Related Epilepsy
    View official trial listing →
  • Recruiting NCT NCT07260006

    Treatment Efficacy of Regimens With and Without Bismuth in Children With Helicobacter Pylori-Associated Peptic Ulcer Disease

    Not yet reported Can Tho University of Medicine and Pharmacy 80 participants Est. completion 2026-05-30 1 site
    Other conditions: Helicobacter Pylori Infection, Peptic Ulcer
    View official trial listing →
  • Recruiting NCT NCT07268820

    Heartburn, Gastroesophageal Reflux Disease

    Not yet reported Incheon St.Mary's Hospital 160 participants Est. completion 2026-09-30 10 sites
    Other conditions: GERD
    View official trial listing →
  • Recruiting NCT NCT07275827

    Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

    Not yet reported Tanta University 88 participants Est. completion 2027-02 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS
    View official trial listing →
  • Recruiting NCT NCT07293910

    Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

    Not yet reported Tanta University 132 participants Est. completion 2026-12-20 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection, Helicobacter Pylori Infected Patients
    View official trial listing →
  • Recruiting NCT NCT07665723

    An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

    Not yet reported Hoffmann-La Roche 25 participants Est. completion 2030-12-31 18 sites Stand-alone
    Other conditions: Active Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT07700953

    A Study to Evaluate the Effects of Low-Fat Meal, High-Fat Meal and Omeprazole Enteric-Coated Tablets on the Pharmacokinetics of ABSK-011 Capsules in Healthy Participants

    Not yet reported Abbisko Therapeutics Co, Ltd 30 participants Est. completion 2026-08-10 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Recruiting NCT NCT07750379

    Assessing the Role of Proton Pump Inhibitors in Reducing Aspiration Incidence in Pediatric Laryngomalacia Cases

    Not yet reported Minia University 60 participants Est. completion 2026-12-31 1 site
    Other conditions: Laryngomalacia
    View official trial listing →
  • Recruiting NCT NCT07791849

    GMPA Versus PPI for Gastric Protection and aGVHD Risk

    Not yet reported First Affiliated Hospital of Zhejiang University 198 participants Est. completion 2028-12-31 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation (HSCT), aGVHD, Infection, Mortality, Microbiome
    View official trial listing →
  • Recruiting NCT NCT07797959

    Thread-Embedding Acupuncture as an Adjunct to Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease

    Not yet reported University of Science Ho Chi Minh City 50 participants Est. completion 2026-09-18 1 site Stand-alone
    Other conditions: GERD, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00001191

    The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2007-12-10 1 site
    Other conditions: Gastrinoma, Zollinger Ellison Syndrome
    View official trial listing →
  • Completed NCT NCT00001337

    Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 348 participants Est. completion 2024-05-24 5 sites Stand-alone
    Other conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Primary Mediastinal Large B-cell Lymphoma, Burkitt Lymphoma, Anaplastic Large-Cell Lymphoma, Gray Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT00002682

    Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

    Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2001-10-08 2 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00003151

    Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 96 participants 22 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00003617

    Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

    Not yet reported Lymphoma Trials Office 200 participants 30 sites
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00045799

    Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill

    Not yet reported Bausch Health Americas, Inc. 354 participants Est. completion 2003-05 58 sites Stand-alone
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT00069823

    Study of Acid Reflux in Asthma

    Not yet reported Johns Hopkins Bloomberg School of Public Health 403 participants Est. completion 2008-05 20 sites
    Other conditions: Asthma, Lung Diseases, Lung Diseases, Obstructive
    View official trial listing →
  • Completed NCT NCT00079833

    Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

    Not yet reported AstraZeneca 25 participants Est. completion 2005-07 8 sites
    Other conditions: Zollinger-Ellison Syndrome
    View official trial listing →
  • Completed NCT NCT00120315

    Proton Pump Inhibitor Treatment Stop

    Not yet reported Odense University Hospital 171 participants Est. completion 2007-03 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT00123656

    Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis

    Not yet reported University of Utah 30 participants Est. completion 2006-12 1 site
    Other conditions: Esophagitis
    View official trial listing →
  • Completed NCT NCT00141102

    Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 4484 participants Est. completion 2009-05 194 sites
    Osteoarthritis Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00149851

    A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)

    Not yet reported Novartis 832 participants Est. completion 2005-06 1 site
    Other conditions: Symptomatic Gastroespohageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00162877

    The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

    Not yet reported National Taiwan University Hospital 80 participants Est. completion 2005-04 1 site
    Other conditions: Peptic Ulcer With H. Pylori Infection, Gastritis With H. Pylori Infection
    View official trial listing →
  • Terminated NCT NCT00164788

    A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole

    Not yet reported Chinese University of Hong Kong 7 participants Est. completion 2011-01 1 site
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT00164840

    Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

    Not yet reported Chinese University of Hong Kong 244 participants Est. completion 2008-11 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00164866

    Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy

    Not yet reported Chinese University of Hong Kong 638 participants Est. completion 2005-09 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00164931

    A Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer

    Not yet reported Chinese University of Hong Kong 240 participants 1 site
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT00170001

    Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy

    Not yet reported Mayo Clinic 500 participants Est. completion 2006-08 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00182260

    A Randomized Controlled Trial of Laparoscopic Nissen Fundoplication Treatment of Patients With Chronic GERD

    Not yet reported McMaster University 216 participants Est. completion 2010-04 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00184522

    On Demand Treatment of Reflux Disease

    Not yet reported Norwegian University of Science and Technology 82 participants Est. completion 2004-12 9 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00201422

    Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

    Not yet reported National Health Research Institutes, Taiwan 70 participants Est. completion 2004-01 1 site Stand-alone
    Other conditions: MALT Lymphoma
    View official trial listing →
  • Completed NCT NCT00206024

    Acid-Associated Heartburn Symptoms and Dose of Esomeprazole

    Not yet reported AstraZeneca 330 participants Est. completion 2005-07 27 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT00206050

    Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po

    Not yet reported AstraZeneca 40 participants Est. completion 2004-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00206180

    NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis

    Not yet reported AstraZeneca 120 participants Est. completion 2005-08 39 sites
    Other conditions: Erosive Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT00206440

    Nexium Study To Suppress Nausea During Chemotherapy

    Not yet reported Baylor Breast Care Center 43 participants Est. completion 2012-02 1 site
    Other conditions: Nausea
    View official trial listing →
  • Completed NCT NCT00210470

    A Phase 2 Clinical Trial of the Safety and Effects of IRX-2 in Treating Patients With Operable Head and Neck Cancer

    Not yet reported Brooklyn ImmunoTherapeutics, LLC 27 participants Est. completion 2012-03 Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Status unknown NCT NCT00216788

    The Effect of Nexium on Transmucosal Esophageal Leak

    Not yet reported Main Line Health 35 participants Est. completion 2006-01 1 site
    Other conditions: Reflux, Esophagitis, Barrett's Esophagus
    View official trial listing →
  • Terminated NCT NCT00222079

    Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy

    Not yet reported Douglas Trask 40 participants Est. completion 2008-02 1 site
    Other conditions: Gastro-esophageal Reflux
    View official trial listing →
  • Completed NCT NCT00222131

    Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients

    Not yet reported University of Kansas Medical Center 73 participants Est. completion 2008-01 1 site
    Other conditions: Indigestion
    View official trial listing →
  • Completed NCT NCT00225238

    The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep

    Not yet reported Thomas Jefferson University 500 participants Est. completion 2007-10 1 site
    Other conditions: Nausea, Vomiting, Abdominal Pain
    View official trial listing →
  • Completed NCT NCT00226044

    Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.

    Not yet reported Rijnstate Hospital 17 participants Est. completion 2017-09 1 site
    Other conditions: Gastroesophageal Reflux, Esophageal Atresia, Hernia, Diaphragmatic
    View official trial listing →
  • Completed NCT NCT00228527

    Esomeprazole for Treatment of GERD in Pediatric Patients

    Not yet reported AstraZeneca 100 participants Est. completion 2005-10 36 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD), Erosive Esophagitis, Non-erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00230516

    Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

    Not yet reported AstraZeneca 100 participants Est. completion 2006-02 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00241501

    Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients

    Not yet reported AstraZeneca 140 participants Est. completion 2005-04 40 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00241514

    Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

    Not yet reported AstraZeneca 334 participants Est. completion 2003-02 113 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00241527

    Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

    Not yet reported AstraZeneca 556 participants Est. completion 2002-09 130 sites
    Other conditions: NSAIDs, Upper GI Symptoms
    View official trial listing →
  • Completed NCT NCT00241540

    Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

    Not yet reported AstraZeneca 808 participants Est. completion 2002-08 119 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00241553

    Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs

    Not yet reported AstraZeneca 276 participants Est. completion 2003-02 136 sites
    Other conditions: NSAIDs, Upper GI Symptoms
    View official trial listing →
  • Completed NCT NCT00242736

    An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 350 participants Est. completion 2006-01 25 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00243724

    HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

    Not yet reported AstraZeneca 350 participants Est. completion 2007-06 10 sites
    Other conditions: Gastroesophageal Reflux, Heartburn, Dyspepsia
    View official trial listing →
  • Withdrawn NCT NCT00247130

    Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

    Not yet reported Keio University Est. completion 2007-07 1 site
    Other conditions: Peptic Ulcers
    View official trial listing →
  • Completed NCT NCT00251030

    A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects

    Not yet reported Pfizer 20 participants Est. completion 2006-01 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00251901

    Chest Pain Pilot Study

    Not yet reported AstraZeneca 600 participants Est. completion 2005-07 80 sites
    Other conditions: Chest Pain, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00251914

    Nexium Dyspepsia/AST

    Not yet reported AstraZeneca 1500 participants Est. completion 2005-01 215 sites
    Other conditions: Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
    View official trial listing →
  • Completed NCT NCT00251927

    Esomeprazole (NEXIUM) vs. Surgery

    Not yet reported AstraZeneca 626 participants Est. completion 2009-04 59 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00251966

    ASTERIX: Low Dose ASA and Nexium

    Not yet reported AstraZeneca 960 participants Est. completion 2005-09 94 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00251979

    A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer

    Not yet reported AstraZeneca 1312 participants Est. completion 2007-12 78 sites
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT00251992

    Nexium Dyspepsia/AST

    Not yet reported AstraZeneca 1200 participants Est. completion 2005-01 183 sites
    Other conditions: Gastrointestinal Disease, Signs and Symptoms, Digestive, Dyspepsia
    View official trial listing →
  • Completed NCT NCT00256737

    Sopran - Omeprazole Treatment Versus Surgery

    Not yet reported AstraZeneca 219 participants Est. completion 2005-10 13 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00259051

    A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

    Not yet reported AstraZeneca 40 participants Est. completion 2004-08 13 sites
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT00259077

    Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population

    Not yet reported AstraZeneca 270 participants Est. completion 2004-07 26 sites
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT00272467

    Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-positive Gastric Ulcer After Eradication Therapy

    Not yet reported Korea Otsuka International Asia Arab 132 participants Est. completion 2008-04 7 sites Stand-alone
    Other conditions: Stomach Ulcer
    View official trial listing →
  • Completed NCT NCT00272701

    Esomeprazole in PPI Failures - IMPROVE

    Not yet reported AstraZeneca 450 participants Est. completion 2007-02 42 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00287339

    The Utility of Nexium in Chronic Cough and Reflux Disease

    Not yet reported University of North Carolina, Chapel Hill 40 participants Est. completion 2008-09 1 site
    Other conditions: Cough, GERD
    View official trial listing →
  • Completed NCT NCT00290823

    Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 110 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Neurocysticercosis
    View official trial listing →
  • Completed NCT NCT00291746

    Validation of RDQ Questionnaire

    Not yet reported AstraZeneca 350 participants Est. completion 2006-11 30 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00295685

    Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD

    Not yet reported Digestive & Liver Disease Specialists 50 participants Est. completion 2007-12 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00298779

    Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants 1 site
    Other conditions: Tumors, Non-Hodgkins's Lymphoma
    View official trial listing →
  • Completed NCT NCT00303264

    The Safety and Efficacy of Dexloxiglumide for the Relief of Symptoms of Functional Dyspepsia.

    Not yet reported Forest Laboratories 48 participants Est. completion 2007-08 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT00317044

    Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

    Not yet reported AstraZeneca 961 participants Est. completion 2008-07 130 sites
    Other conditions: Asthma, GERD
    View official trial listing →
  • Completed NCT NCT00318084

    PPI Test in GP Patients

    Not yet reported AstraZeneca 100 participants 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00318968

    Nexium RESPONSE Trial

    Not yet reported AstraZeneca 1000 participants Est. completion 2007-11 38 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00325715

    AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers

    Not yet reported Allergan 150 participants Est. completion 2006-08 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00327132

    Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome

    Not yet reported National Health Research Institutes, Taiwan 47 participants Est. completion 2015-12 6 sites Stand-alone
    Other conditions: Gastric MALT Lymphoma
    View official trial listing →
  • Terminated NCT NCT00332748

    A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer

    Not yet reported Bristol-Myers Squibb 36 participants 4 sites
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT00339768

    A Randomized Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Lingu, Shandong Province

    Not yet reported National Cancer Institute (NCI) 3411 participants Est. completion 1996-06-10 1 site Stand-alone
    Other conditions: Precancerous Gastric Lesions
    View official trial listing →
  • Completed NCT NCT00343161

    Symptom Adapted Therapy in GERD Patients

    Not yet reported AstraZeneca 441 participants Est. completion 2007-08 96 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00349661

    Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel

    Not yet reported University Hospital, Brest 120 participants Est. completion 2006-12 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00350155

    Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel

    Not yet reported Novartis 150 participants 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00352261

    An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients

    Not yet reported AstraZeneca 80 participants Est. completion 2007-04 12 sites
    Other conditions: Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT00355615

    PLUTO: Pediatric Lipid-redUction Trial of rOsuvastatin

    Not yet reported AstraZeneca 173 participants Est. completion 2008-07 20 sites
    Other conditions: Familial Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00357240

    Drug Interaction Study With Proton Pump Inhibitor

    Not yet reported Bristol-Myers Squibb 56 participants Est. completion 2006-08 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00357682

    A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

    Not yet reported University of Oxford 2557 participants Est. completion 2017-05-31
    Other conditions: Esophageal Cancer, Precancerous Condition
    View official trial listing →
  • Withdrawn NCT NCT00361985

    Study of Proton Pump Inhibitors (PPI) to Prevent Strictures After Gastric Bypass Surgery

    Not yet reported Weill Medical College of Cornell University Est. completion 2011-07 1 site
    Other conditions: Anastomotic Stricture, Morbid Obesity
    View official trial listing →
  • Status unknown NCT NCT00363701

    Study of Long-Term Use of Proton-Pump-Inhibitors in General Practice

    Not yet reported Glostrup University Hospital, Copenhagen 150 participants Est. completion 2008-02 1 site
    Other conditions: Dyspepsia, Gastroesophageal Refluxdisease, Ulcer
    View official trial listing →
  • Withdrawn NCT NCT00364481

    Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome

    Not yet reported West Side ENT Est. completion 2007-08
    Obstructive sleep apnea Other conditions: Upper Airway Resistance Syndrome, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00365313

    Preventing Recurrent Ulcer Bleeding in Arthritis Patients Using Esomeprazole Plus Celecoxib

    Not yet reported Chinese University of Hong Kong 273 participants Est. completion 2005-06 1 site
    Other conditions: Arthritis, Bleeding Ulcer
    View official trial listing →
  • Completed NCT NCT00367211

    Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

    Not yet reported POZEN 400 participants Est. completion 2007-09 1 site
    Osteoarthritis Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00374101

    High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding

    Not yet reported Casa Sollievo della Sofferenza IRCCS 450 participants Est. completion 2007-03 10 sites
    Other conditions: Peptic Ulcers, Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT00384592

    PPI Sequencing Study

    Not yet reported AstraZeneca 100 participants Est. completion 2007-05 14 sites
    Other conditions: Gastro-Oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00392002

    Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response

    Not yet reported AstraZeneca 2000 participants Est. completion 2007-05 2 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00401583

    A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2008-02-20 2 sites Stand-alone
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00401752

    Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric Ulcer

    Not yet reported AstraZeneca 397 participants Est. completion 2008-11 9 sites
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00402259

    Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding

    Not yet reported AstraZeneca 440 participants Est. completion 2007-10 7 sites
    Other conditions: Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT00404534

    Helicobacter Eradication Relief of Dyspeptic Symptoms

    Not yet reported Hospital de Clinicas de Porto Alegre 407 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Completed NCT NCT00405119

    A Study To Investigate The Effectiveness Of AH234844 (Lavoltidine) Compared With NEXIUM And Ranitidine.

    Not yet reported GlaxoSmithKline 92 participants Est. completion 2007-03 2 sites
    Other conditions: Gastroesophageal Reflux Disease, Reflux, Gastroesophageal
    View official trial listing →
  • Completed NCT NCT00410592

    Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD

    Not yet reported AstraZeneca 90 participants Est. completion 2007-05 8 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00420615

    Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies

    Not yet reported Novartis Pharmaceuticals 34 participants 1 site Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00426452

    A Drug-drug Interaction Study of Oral 1250 mg of Vatalinib Administered Under Fasting and Fed Conditions With a Proton-pump Inhibitor in Healthy Sterile or Postmenopausal Female Volunteers

    Not yet reported Novartis 24 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00426595

    Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation

    Not yet reported University Hospital, Ghent 14 participants Est. completion 2007-11 1 site
    Other conditions: Gastreoesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00427635

    Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients

    Not yet reported AstraZeneca 32 participants Est. completion 2009-04 3 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00428701

    An Open-label, Exploratory Trial to Assess Gastric Acid Control in Critically Ill Subjects Receiving Nexium

    Not yet reported AstraZeneca 40 participants Est. completion 2006-11 5 sites
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00441519

    A Parallel Group Study to Compare the Gastroprotective Effects of PA 325 Versus 81 mg Enteric Coated Aspirin

    Not yet reported POZEN 80 participants Est. completion 2007-04 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00441727

    Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)

    Not yet reported AstraZeneca 2426 participants Est. completion 2008-08 189 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT00442052

    To Compare the Gastroprotective Effects and Pharmacokinetic Profile of PA Versus Enteric-Coated Aspirin

    Not yet reported POZEN 80 participants Est. completion 2007-01 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00442208

    An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers

    Not yet reported POZEN 24 participants Est. completion 2008-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00442741

    Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)

    Not yet reported Novartis Pharmaceuticals Stand-alone
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00443170

    A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

    Not yet reported GlaxoSmithKline 90 participants 3 sites
    Other conditions: Healthy Subjects, Anaemia
    View official trial listing →
  • Withdrawn NCT NCT00443963

    Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs

    Not yet reported Medstar Health Research Institute Est. completion 2006-12 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Terminated NCT NCT00444236

    Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression

    Not yet reported University of Utah 31 participants Est. completion 2009-09 1 site
    Other conditions: Exercise Triggered Asthma, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00444275

    Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients

    Not yet reported AstraZeneca 3029 participants Est. completion 2008-10 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00446004

    Effect of a Proton Pump Inhibitor on Gleevec® in Healthy Volunteers

    Not yet reported University of Pittsburgh 15 participants Est. completion 2009-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT00455754

    Esomeprazole Treatment for Patients With Lymphocytic Gastritis

    Not yet reported Technische Universität Dresden 40 participants Est. completion 2009-12 1 site
    Other conditions: Lymphocytic Gastritis
    View official trial listing →
  • Status unknown NCT NCT00455806

    Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection

    Not yet reported Technische Universität Dresden 132 participants Est. completion 2008-02 9 sites
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Completed NCT NCT00464308

    A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

    Not yet reported Janssen-Cilag Pty Ltd 1392 participants Est. completion 2008-05 25 sites
    Other conditions: Gastro-oesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00468559

    Phase 3/Safety & Efficacy of Esomeprazole in Infants

    Not yet reported AstraZeneca 98 participants Est. completion 2008-06 25 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Status unknown NCT NCT00471029

    Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer

    Not yet reported Pamela Youde Nethersole Eastern Hospital 20 participants Est. completion 2007-09 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00472550

    Esomeprazole and Gastric Emptying of Beer

    Not yet reported Heidelberg University 16 participants Est. completion 2006-11 1 site
    Other conditions: Gastroesophageal Reflux, Heartburn
    View official trial listing →
  • Completed NCT NCT00473980

    Preoperative Non-steroidal Anti-inflammatory Drugs(NSAID) to Colorectal Cancer Patients

    Not yet reported Göteborg University 28 participants Est. completion 2007-05 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00474019

    Phase 1 Pharmacokinetics of Intravenous Nexium in Children

    Not yet reported AstraZeneca 42 participants Est. completion 2009-10 15 sites
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT00474903

    Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus

    Not yet reported National Cancer Institute (NCI) 122 participants Est. completion 2011-06 1 site
    Other conditions: Barrett Esophagus, Esophageal Cancer
    View official trial listing →
  • Withdrawn NCT NCT00475527

    Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy

    Not yet reported Hadassah Medical Organization 1 site Stand-alone
    Other conditions: Anemia, Iron-Deficiency, Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT00492622

    Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis

    Not yet reported University of Louisville 12 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Gastroparesis, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00501774

    A Search for Helicobacter Pylori in Localized Vulvodynia

    Western Galilee Hospital-Nahariya 27 participants Est. completion 2007-06 1 site
    Other conditions: Vulvodynia, Vulvar Vestibulitis
    View official trial listing →
  • Status unknown NCT NCT00516971

    The Use of Proton Pump Inhibitor for the Treatment of Non-erosive Gastro-oesophageal Reflux Disease in Chinese Population

    Not yet reported Hospital Authority, Hong Kong 200 participants Est. completion 2008-12 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00519519

    Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers

    Not yet reported Singapore General Hospital 126 participants Est. completion 2007-11 4 sites
    Other conditions: Bleeding Peptic Ulcers Disease
    View official trial listing →
  • Completed NCT NCT00520949

    Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori Infection

    Not yet reported Aga Khan University 176 participants Est. completion 2008-06 1 site
    Other conditions: Treatment of Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT00524251

    The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

    AstraZeneca 990 participants Est. completion 2008-03 54 sites
    Other conditions: GERD, Quality of Life
    View official trial listing →
  • Status unknown NCT NCT00526006

    PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena

    Not yet reported Zealand University Hospital Est. completion 2008-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00527904

    A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)

    Not yet reported POZEN 239 participants Est. completion 2009-03 1 site
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Terminated NCT NCT00537732

    Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-adjusted Dosing

    Not yet reported Matthias Schwab 68 participants Est. completion 2010-12 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Terminated NCT NCT00542347

    Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole

    Not yet reported Queen's University 20 participants Est. completion 2018-07 1 site
    Other conditions: Gastric Acid
    View official trial listing →
  • Completed NCT NCT00542789

    Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

    Not yet reported AstraZeneca 343 participants Est. completion 2009-02 39 sites
    Osteoarthritis Other conditions: Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Lumbago
    View official trial listing →
  • Completed NCT NCT00557349

    Ulcer Prevention Study in Post Gastric Bypass Patients

    Not yet reported University of Missouri-Columbia 40 participants Est. completion 2008-03 1 site
    Other conditions: Marginal Ulcers
    View official trial listing →
  • Terminated NCT NCT00557921

    Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

    Not yet reported Cogentus Pharmaceuticals 5000 participants Est. completion 2009-11 491 sites Stand-alone
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT00559182

    A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

    Not yet reported Merck Sharp & Dohme LLC 47 participants Est. completion 2010-07-09 Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT00559364

    Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

    Not yet reported Forest Laboratories 50 participants Est. completion 2009-07 18 sites Stand-alone
    Other conditions: Exocrine Pancreatic Insufficiency, Chronic Pancreatitis, Pancreatectomy
    View official trial listing →
  • Completed NCT NCT00564330

    In Vivo Quantification of Dental Demineralisation Using OCT With and Without Esomeprazole

    Not yet reported, Not yet reported Brain-Gut Research Group 30 participants Est. completion 2008-05
    Other conditions: Tooth Erosion
    View official trial listing →
  • Status unknown NCT NCT00564590

    SThe Effects of Melatonin on GERD Symptoms

    Not yet reported, Not yet reported Rabin Medical Center 150 participants Est. completion 2011-01 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Withdrawn NCT NCT00567658

    Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas

    Not yet reported Vanderbilt University Est. completion 2010-01 1 site
    Other conditions: Larynx Disease
    View official trial listing →
  • Completed NCT NCT00574925

    Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

    Not yet reported University of Zurich Est. completion 2007-10 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00582972

    Does Omeprazole Decrease Intestinal Calcium Absorption?

    Not yet reported University of Wisconsin, Madison 23 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Osteoporosis, Achlorhydria, GERD, Hip Fracture
    View official trial listing →
  • Completed NCT NCT00584922

    Early Detection and Treatment of Esophageal Injury After Catheter Ablation for Atrial Fibrillation

    University of Oklahoma 175 participants Est. completion 2011-12 1 site
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00590928

    Gastric pH in Critically Ill Patients

    Not yet reported Medical University of Vienna 75 participants Est. completion 2006-06 1 site
    Other conditions: Critically Ill Patients, Indication for Stress Ulcer Prophylaxis
    View official trial listing →
  • Completed NCT NCT00595517

    Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

    Not yet reported AstraZeneca 395 participants Est. completion 2009-09 3 sites
    Osteoarthritis Other conditions: Gastric Ulcer, Duodenal Ulcer, Rheumatoid Arthritis, Lumbago
    View official trial listing →
  • Terminated NCT NCT00604942

    vMII for Measurement of Oesophageal Bolus Transport and Reflux

    Not yet reported Guy's and St Thomas' NHS Foundation Trust 140 participants Est. completion 2010-10 1 site
    Other conditions: Achalasia, GORD
    View official trial listing →
  • Completed NCT NCT00608712

    Use Of Esomeprazole In Postoperative Bariatric Surgery Patients Users And Non-Users Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)

    Not yet reported AstraZeneca 140 participants Est. completion 2006-08
    Other conditions: Postoperative Bariatric Surgery
    View official trial listing →
  • Completed NCT NCT00612027

    Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions

    AstraZeneca 29586 participants
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT00620802

    Pharmacodynamics of CGT 2168 Compared With Plavix®

    Not yet reported Cogentus Pharmaceuticals 60 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00625274

    A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients

    Not yet reported AstraZeneca 100 participants Est. completion 2004-11
    Other conditions: Heartburn, Upper Abdominal Pain, Nausea, Acid Regurgitation
    View official trial listing →
  • Completed NCT NCT00625495

    Study Comparing the Effects of Esomeprazole Adminstered Orally and Intravenously on Basal and Pentrigastrin-stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 60 participants Est. completion 2002-11
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00626262

    Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

    Not yet reported AstraZeneca 60 participants Est. completion 2002-10
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00626535

    A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)

    Not yet reported AstraZeneca 500 participants Est. completion 2004-02
    Other conditions: Symptomatic Gastroesophageal Reflux Disease (sGERD)
    View official trial listing →
  • Completed NCT NCT00628342

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 600 participants Est. completion 2003-08
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00628667

    Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux

    Not yet reported AstraZeneca 120 participants Est. completion 2003-03
    Other conditions: Chronic Posterior Laryngitis (CPL)
    View official trial listing →
  • Completed NCT NCT00628953

    Adult Asthmatics and Acid Reflux

    Not yet reported AstraZeneca 1400 participants Est. completion 2004-04
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00629512

    Prevention of Gastric Ulcers

    Not yet reported AstraZeneca 504 participants Est. completion 2002-12
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00629564

    An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 60 participants Est. completion 2002-10
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00629928

    Ulcer Prevention II

    Not yet reported AstraZeneca 800 participants Est. completion 2003-03
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00632086

    Evaluate Relative Bioavailability of PA32540 (Asa/Omeprazole), Its Aspirin Component, and Ecotrin® in Healthy Volunteers

    Not yet reported POZEN 36 participants Est. completion 2008-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00633035

    Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit

    Not yet reported Far Eastern Memorial Hospital 60 participants Est. completion 2010-04 1 site
    Other conditions: Ulcer
    View official trial listing →
  • Completed NCT NCT00633412

    A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only

    Not yet reported AstraZeneca 400 participants Est. completion 2003-03
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00633672

    A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued

    Not yet reported AstraZeneca 400 participants Est. completion 2003-10
    Other conditions: NSAID Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00633932

    Reflux Esophagitis Phase III Study (Initial Treatment)

    Not yet reported AstraZeneca 602 participants Est. completion 2008-12 41 sites
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT00634114

    Reflux Esophagitis Phase III Study (Maintenance Treatment)

    Not yet reported AstraZeneca 540 participants Est. completion 2009-05 44 sites Stand-alone
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT00635414

    Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously

    Not yet reported AstraZeneca 60 participants Est. completion 2002-10
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT00637559

    Barrett's Esophagus - 315 - 3 Way Cross-Over

    Not yet reported AstraZeneca 50 participants Est. completion 2003-04
    Other conditions: Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT00637845

    Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 248 participants Est. completion 2003-02
    Other conditions: Heartburn, Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00637988

    Barrett's Esophagus - 315 - 3 Way Cross Over

    Not yet reported AstraZeneca 32 participants Est. completion 2003-06
    Other conditions: Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT00640809

    Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 408 participants Est. completion 2004-04 12 sites
    Other conditions: Bowel Diseases, Inflammatory
    View official trial listing →
  • Completed NCT NCT00641004

    Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy

    Not yet reported Otsuka Pharmaceutical, Inc., Philippines 30 participants Est. completion 2010-03 4 sites
    Other conditions: NSAID Induced Gastropathy
    View official trial listing →
  • Completed NCT NCT00641264

    Quality of Life Validation in Laryngitis

    Not yet reported AstraZeneca 90 participants Est. completion 2003-06
    Other conditions: Laryngopharyngeal Reflux (LPR)
    View official trial listing →
  • Completed NCT NCT00641602

    A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

    Not yet reported AstraZeneca 1000 participants Est. completion 2003-08
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00644735

    Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

    Not yet reported AstraZeneca 750 participants Est. completion 2004-01
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00644839

    Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

    Not yet reported Pfizer 28 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00655746

    The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 14 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00656968

    Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 232 participants Est. completion 2010-06 2 sites
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Completed NCT NCT00658528

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1061 participants Est. completion 2010-01 88 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658632

    Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1397 participants Est. completion 2009-09 85 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00658775

    Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

    Not yet reported Eisai Inc. 1069 participants Est. completion 2010-01 83 sites
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT00660660

    Local Phase IV, Gastroesophageal Reflux Disease (GERD) Sleep Study US

    Not yet reported AstraZeneca 276 participants Est. completion 2008-07 45 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT00664209

    Treating H. Pylori in Parkinson's Patients With Motor Fluctuations

    Not yet reported University of California, Los Angeles 64 participants Est. completion 2012-06 1 site
    Other conditions: Parkinson's Disease, Helicobacter Infections, Motor Fluctuations
    View official trial listing →
  • Terminated NCT NCT00668317

    Bronchial Hyper-responsiveness in Reflux Cough

    Not yet reported Hull University Teaching Hospitals NHS Trust 5 participants Est. completion 2010-01 1 site
    Other conditions: Cough
    View official trial listing →
  • Completed NCT NCT00669955

    Efficacy and Safety of Quadruple Therapy in Eradication of H. Pylori: A Comparison to Triple Therapy

    Not yet reported Forest Laboratories 440 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT00674115

    A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

    Not yet reported Bayer 60 participants Est. completion 2008-06 Stand-alone
    Other conditions: Gastric Acid, Human Experimentation
    View official trial listing →
  • Completed NCT NCT00676117

    Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males

    Not yet reported AstraZeneca 30 participants Est. completion 2008-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00683111

    Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease

    Not yet reported Ruttonjee Hospital 500 participants Est. completion 2011-12 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00684190

    Drug Interaction Study Between AZD3355 and Nexium

    Not yet reported AstraZeneca 30 participants Est. completion 2008-06 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00687245

    Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)

    Not yet reported AstraZeneca 40 participants Est. completion 2008-05
    Other conditions: Endoscopically-Proven GERD, Reflux
    View official trial listing →
  • Completed NCT NCT00688428

    Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination

    Not yet reported AstraZeneca 84 participants Est. completion 2008-04
    Other conditions: Ulcers, Upper GI Symptoms
    View official trial listing →
  • Completed NCT NCT00692510

    Drug Interaction Study Between AZD3480 and Cytochrome P450

    Not yet reported AstraZeneca 18 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Metabolism, Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT00693225

    Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

    Not yet reported Yvonne Romero 91 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT00699426

    The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

    Not yet reported Lise Tarnow 41 participants Est. completion 2009-06
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00700687

    Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

    Not yet reported POZEN 90 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00712413

    Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori

    Not yet reported Forest Laboratories Est. completion 2008-12 3 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT00719160

    The Effect of Protein on Calcium Absorption and Gastric Acid Production

    Not yet reported Yale University 12 participants Est. completion 2008-05 1 site
    Other conditions: Osteoporosis
    View official trial listing →
  • Completed NCT NCT00719420

    Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia

    Not yet reported University of North Texas Health Science Center 151 participants Est. completion 2007-02 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT00723502

    Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected Patients

    Not yet reported MerLion Pharmaceuticals GmbH 30 participants Est. completion 2009-04 1 site
    Other conditions: Gram-Negative Bacterial Infections, Helicobacter Infections, Dyspepsia
    View official trial listing →
  • Completed NCT NCT00726726

    Drug Interaction Study With a Potential Alzheimer's Disease Compound

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT00728481

    The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis

    Not yet reported, Not yet reported Mayo Clinic 51 participants Est. completion 2010-12 1 site
    Other conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease, EE, GERD
    View official trial listing →
  • Terminated NCT NCT00730665

    Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)

    Not yet reported Pfizer 81 participants Est. completion 2008-10 38 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00734097

    A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

    Not yet reported AstraZeneca 314 participants Est. completion 2008-10 10 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00741468

    Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects

    Not yet reported Repros Therapeutics Inc. 18 participants Est. completion 2008-10 1 site Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT00745849

    Efficacy of Esomeprazole for Non-Allergic Rhinitis: A Double-blind, Placebo Controlled Trial

    Not yet reported University of Texas Southwestern Medical Center 43 participants Est. completion 2008-03 1 site
    Other conditions: Vasomotor Rhinitis
    View official trial listing →
  • Completed NCT NCT00746733

    Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC

    Not yet reported Shire 24 participants Est. completion 2008-10-26 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00749385

    A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels

    Not yet reported POZEN 40 participants Est. completion 2008-10 1 site
    Other conditions: Arthritis
    View official trial listing →
  • Completed NCT NCT00765206

    A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

    Not yet reported Bayer 60 participants Est. completion 2008-08 Stand-alone
    Other conditions: Gastric Acid, Human Experimentation
    View official trial listing →
  • Completed NCT NCT00772837

    Effect of Eradication of Helicobacter Pylori on the Dyspeptic Symptoms

    Not yet reported Aga Khan University 370 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Functional Dyspepsia, Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT00786695

    Study Using Esomeprazole as a Diagnostic Test for GERD in Patients With NCCP

    Not yet reported National University Hospital, Singapore 60 participants Est. completion 2009-12 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00808769

    Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression

    Not yet reported Procter and Gamble 30 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Normal Healthy Subject Population
    View official trial listing →
  • Completed NCT NCT00817245

    Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)

    Not yet reported, Not yet reported Tabriz University 50 participants Est. completion 2009-01 1 site
    Other conditions: Central Serous Chorioretinopathy
    View official trial listing →
  • Completed NCT NCT00818870

    Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

    Not yet reported Vecta Ltd. 60 participants Est. completion 2009-06 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT00825630

    13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

    Not yet reported Meridian Bioscience, Inc. 123 participants Est. completion 2009-11 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT00838682

    Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers

    Not yet reported The Catholic University of Korea 106 participants Est. completion 2009-03 2 sites
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT00843453

    Long-term Use of Proton Pump Inhibitors May Cause Vitamin B12 Deficiency in the Institutionalized Elderly

    Not yet reported University of Delaware 36 participants Est. completion 2008-04 2 sites
    Other conditions: Vitamin B12 Deficiency
    View official trial listing →
  • Completed NCT NCT00849329

    A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast Cancer

    Not yet reported GlaxoSmithKline 12 participants Est. completion 2009-11-24 4 sites
    Other conditions: Neoplasms, Breast
    View official trial listing →
  • Completed NCT NCT00854451

    Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori Infection

    Not yet reported National Taiwan University Hospital 128 participants Est. completion 1998-02 1 site
    Other conditions: Duodenal Ulcer, Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT00857597

    Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD Treatment

    Not yet reported University of Pittsburgh 60 participants Est. completion 2011-12 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Status unknown NCT NCT00861640

    Comparison of Oral Rabeprazole vs. iv Omeprazole in Mild to Moderate Nonvariceal Upper Gastrointestinal Bleeding

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 200 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Nonvariceal Upper Gastrointestinal Bleeding
    View official trial listing →
  • Withdrawn NCT NCT00881413

    Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

    Not yet reported Lotung Poh-Ai Hospital
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT00895817

    Fluticasone Versus Esomeprazole to Treat Eosinophilic Esophagitis

    Not yet reported Walter Reed Army Medical Center 42 participants Est. completion 2010-10 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT00903448

    Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

    Not yet reported Procter and Gamble 40 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00915616

    The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease

    Not yet reported Mansoura University
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT00930306

    AZD2066 Cocktail Study

    Not yet reported AstraZeneca 15 participants Est. completion 2009-09 2 sites Stand-alone
    Other conditions: Chronic Pain
    View official trial listing →
  • Completed NCT NCT00930670

    Evaluation of the Influence of Statins and Proton Pump Inhibitors on Clopidogrel Antiplatelet Effects

    Not yet reported Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec 320 participants Est. completion 2011-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00931073

    A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

    Not yet reported Pfizer 24 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Alzheimer's Disease, Huntington's Disease
    View official trial listing →
  • Completed NCT NCT00942136

    GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT00942175

    A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

    Not yet reported Takeda 160 participants Est. completion 2010-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00950339

    Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or Famotidine

    Not yet reported Tel-Aviv Sourasky Medical Center 63 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Coronary Heart Disease, GI Bleeding
    View official trial listing →
  • Completed NCT NCT00951431

    Gastric Functions & Proton Pump Inhibitor( PPI) Study

    Not yet reported Chinese University of Hong Kong 155 participants Est. completion 2016-02-19 1 site
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Completed NCT NCT00952978

    Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)

    Not yet reported Livzon Pharmaceutical Group Inc. 496 participants Est. completion 2006-05 1 site
    Other conditions: Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT00953381

    Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)

    Not yet reported Livzon Pharmaceutical Group Inc. 235 participants Est. completion 2005-05 1 site
    Other conditions: Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT00960869

    Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

    Not yet reported POZEN 519 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00961350

    A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

    Not yet reported POZEN 530 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT00963027

    Effect of Esomeprazole on the Pharmacokinetics of Oral Treprostinil

    Not yet reported United Therapeutics 30 participants Est. completion 2009-10 1 site
    Other conditions: Hypertension, Pulmonary, Pulmonary Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT00964106

    Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation

    Not yet reported GlaxoSmithKline 87 participants Est. completion 2011-08-29 2 sites Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT00971581

    Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus Omeprazole

    Not yet reported Sanofi 52 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT00978016

    A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

    Not yet reported XenoPort, Inc. 460 participants Est. completion 2010-12 64 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT00978159

    Esomeprazole or Famotidine in the Management of Aspirin Related Non-Ulcer Dyspepsia

    Not yet reported Ruttonjee Hospital 128 participants Est. completion 2013-12 2 sites
    Other conditions: Aspirin, Dyspepsia
    View official trial listing →
  • Terminated NCT NCT00981929

    Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes

    Not yet reported University of Southern Denmark 412 participants Est. completion 2011-01 1 site
    Other conditions: Cytochrome P450 Phenotype and Genotype Metrics
    View official trial listing →
  • Completed NCT NCT00989300

    Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel

    Not yet reported Janssen Cilag S.A.S. 39 participants Est. completion 2010-03 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00994708

    The Effect of Esomeprazole and Fundoplication on Airways

    Not yet reported Tampere University Hospital 1 site
    Other conditions: Airway Responsiveness
    View official trial listing →
  • Completed NCT NCT00995410

    Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers

    Not yet reported POZEN 380 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Aspirin-Associated Gastric Ulcers
    View official trial listing →
  • Completed NCT NCT00998075

    Study Comparing Esomeprazole and Acetylsalicylic Acid (ASA) Combined Together as One Capsule Versus These Medications Taken Separately

    Not yet reported AstraZeneca 138 participants Est. completion 2009-12 1 site
    Other conditions: Peptic Ulcer Disease
    View official trial listing →
  • Status unknown NCT NCT01000220

    Evaluation of Omeprazole Effect on Glaucoma

    Not yet reported Shahid Beheshti University of Medical Sciences 1 site
    Other conditions: Glaucoma
    View official trial listing →
  • Completed NCT NCT01000818

    A Study to Evaluate the Effect of Famotidine and Omeprazole on MK0518 (Raltegravir) Pharmacokinetics in Human Immunodeficiency Virus (HIV)-Infected Patients (0518-054)

    Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2009-03 Stand-alone
    Other conditions: HIV-1 Infection, HIV Infections
    View official trial listing →
  • Completed NCT NCT01001247

    TMC278-TiDP6-C154: Evaluation of the Possible Influence of Omeprazole Intake - and the pH Increase in the Stomach Triggered by Omeprazole Intake - on the Blood Levels of TMC278 in Healthy Volunteers

    Not yet reported Tibotec Pharmaceuticals, Ireland 18 participants Est. completion 2010-04
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT01001299

    A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

    Not yet reported Hoffmann-La Roche 25 participants Est. completion 2012-02-29 5 sites Stand-alone
    Other conditions: Malignant Melanoma
    View official trial listing →
  • Completed NCT NCT01002443

    Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

    Not yet reported National Cancer Center, Korea 190 participants Est. completion 2009-03 1 site
    Other conditions: Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01005719

    Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)

    Not yet reported Bayer 63 participants Est. completion 2010-01 Stand-alone
    Other conditions: Human Experimentation
    View official trial listing →
  • Completed NCT NCT01007019

    Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH4808 After Oral Administration in Healthy Male Subjects

    Not yet reported Yuhan Corporation 134 participants Est. completion 2012-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01015729

    Study Comparing Esomeprazole and ASA Combined Together as One Capsule Versus These Medications Taken Separately

    Not yet reported AstraZeneca 30 participants Est. completion 2010-03 1 site
    Other conditions: Peptic Ulcer Disease
    View official trial listing →
  • Withdrawn NCT NCT01016717

    Clopidogrel Proton-Pump Inhibitors Study

    Not yet reported Sheba Medical Center Est. completion 2012-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01018940

    Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease

    University of Oklahoma 30 participants Est. completion 2011-06 1 site
    Cardiovascular disease Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Status unknown NCT NCT01023360

    Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Mapping ™ Assay

    Not yet reported National Taiwan University Hospital 30 participants Est. completion 2010-10 1 site
    Other conditions: 30 Healthy People
    View official trial listing →
  • Completed NCT NCT01032655

    The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection

    Not yet reported National Taiwan University Hospital 134 participants Est. completion 2012-03 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01042704

    Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

    Not yet reported Robert Redner, MD 29 participants Est. completion 2015-03 22 sites Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT01045434

    Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsule Under Fed Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 62 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01045642

    Bioequivalence Study of Omeprazole Magnesium 20 mg DR Capsules Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 38 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01059383

    Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD Symptoms

    Not yet reported Vecta Ltd. 52 participants Est. completion 2011-06 2 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01061034

    Pharmacological Study That Measures Omeprazole Effect on Aspirins Absorption in Healthy Volunteers

    Not yet reported Assaf-Harofeh Medical Center 9 participants Est. completion 2007-06 1 site
    Other conditions: Aspirin Blood Level, Proton Pump Inhiditor Treatment
    View official trial listing →
  • Completed NCT NCT01062516

    Influence of Esomeprazole on Antiplatelet Action of Clopidogrel Associated With Aspirin

    Not yet reported Ruttonjee Hospital 100 participants Est. completion 2010-09 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT01069081

    Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

    Not yet reported Fudan University 94 participants Est. completion 2012-02 1 site
    Other conditions: Breast Cancer, Metastasis, Neoplasm
    View official trial listing →
  • Completed NCT NCT01069939

    Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

    Not yet reported AstraZeneca 427 participants Est. completion 2011-11 46 sites
    Other conditions: Prevention
    View official trial listing →
  • Completed NCT NCT01077076

    Pharmacodynamic Study Comparing the Effects of Two Different Forms of Omeprazole (P07812) (COMPLETED)

    Not yet reported Bayer 30 participants Est. completion 2009-03 Stand-alone
    Other conditions: Intragastric Acidity
    View official trial listing →
  • Completed NCT NCT01079884

    Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance

    Not yet reported David A. Johnson, MD 18 participants Est. completion 2011-03 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT01085786

    Sequential and Hybrid Therapies for H Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 240 participants Est. completion 2010-05 2 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01086722

    Pharmacokinetics in Morbid Obesity After Bariatric Surgery

    Not yet reported, Not yet reported Fundacion IMIM 52 participants Est. completion 2013-03 2 sites
    Other conditions: Morbid Obesity, Overweight
    View official trial listing →
  • Status unknown NCT NCT01089959

    Effect of Esomeprazole 40 mg.Daily for 7 Days on Acid Reflux and Related Arousals During Sleep in Patients With GERD

    Not yet reported, Not yet reported Southern Arizona VA Health Care System 20 participants Est. completion 2012-03 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01093755

    Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

    Not yet reported Mayo Clinic 30 participants Est. completion 2014-11 1 site
    Other conditions: Inflammation, Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT01094275

    Role of CYP2C19 Polymorphism in the Drug Interaction Between Clopidogrel and Omeprazole

    Neil Kleiman, MD 75 participants Est. completion 2014-06-30 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01107938

    Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 330 participants
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Terminated NCT NCT01109381

    Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori

    Not yet reported, Not yet reported Synergy Pharmaceuticals Pte. Ltd. 33 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01119768

    Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients

    Not yet reported AstraZeneca 305 participants Est. completion 2011-06 8 sites
    Other conditions: Non Erosive Reflux Disease, Chronic Gastritis
    View official trial listing →
  • Completed NCT NCT01121029

    Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Dra. Olga Graciela Cantu Rodriguez 15 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01122160

    Gastric pH and Anthocyanin Absorption

    Not yet reported USDA Beltsville Human Nutrition Research Center 13 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Anthocyanin Metabolism
    View official trial listing →
  • Withdrawn NCT NCT01123031

    Oral vs Intravenous and Proton Pump Inhibitor (PPI)for Peptic Ulcer Bleeding (PUB)

    Not yet reported Changhua Christian Hospital Est. completion 2012-03
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01129375

    Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

    Not yet reported Sanofi 72 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01129388

    Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy Subjects

    Not yet reported Sanofi 72 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01129414

    Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

    Not yet reported Sanofi 72 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01129713

    Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

    Not yet reported, Not yet reported Effexus Pharmaceutical 40 participants Est. completion 2015-05 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD), Heartburn, Indigestion
    View official trial listing →
  • Terminated NCT NCT01129778

    Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus

    Not yet reported Stanford University 27 participants Est. completion 2010-12 1 site
    Other conditions: Barrett Esophagus, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01130935

    Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium

    AstraZeneca 491 participants Est. completion 2010-11 14 sites
    Other conditions: Gastric Acid Suppression, Proton Pump Inhibitors
    View official trial listing →
  • Completed NCT NCT01132638

    Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux Disease

    Not yet reported Takeda 713 participants Est. completion 2012-06 9 sites
    Other conditions: GERD
    View official trial listing →
  • Active, not recruiting NCT NCT01133951

    Helicobacter Pylori Eradication to Prevent Gastric Cancer

    Not yet reported Jie-Jun Wang 3000 participants Est. completion 2032-05 1 site Stand-alone
    Other conditions: Helicobacter Infections, Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT01135472

    Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2012-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01136317

    Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

    Not yet reported Nantes University Hospital Est. completion 2010-07 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01138969

    Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer

    Not yet reported Kaohsiung Veterans General Hospital. 165 participants Est. completion 2012-12 1 site
    Other conditions: Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT01139645

    The Effect of Proton Pump Inhibitors on Calcium and Bone Metabolism

    Not yet reported American University of Beirut Medical Center 58 participants Est. completion 2010-07 1 site
    Other conditions: Calcium Metabolism Disorders
    View official trial listing →
  • Terminated NCT NCT01142128

    Viokase 16, Viokase16 Plus Nexium and Nexium Alone

    Not yet reported University of Florida 12 participants Est. completion 2012-03 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Completed NCT NCT01142245

    Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy

    Not yet reported Chinese University of Hong Kong 263 participants Est. completion 2014-07 2 sites
    Other conditions: Peptic Ulcer, Bleeding
    View official trial listing →
  • Completed NCT NCT01146197

    Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 33 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Gitelman Syndrome
    View official trial listing →
  • Completed NCT NCT01147588

    Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of Clopidogrel

    Not yet reported AstraZeneca 149 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01147887

    A Pharmacokinetic and Drug Interaction Study of JNJ-26489112 in Healthy Volunteers

    Not yet reported Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20 participants Est. completion 2010-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01150162

    Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety Evaluation

    Not yet reported Otsuka Pakistan Limited 129 participants Est. completion 2012-08 3 sites Stand-alone
    Other conditions: Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT01153659

    A Study to Evaluate the Effect on 24-hour, Intragastric pH of RAB ER 50-mg Capsules Compared With Esomeprazole (Nexium) 40 mg Capsules and Rabeprazole (Aciphex) 20-mg Tablets

    Not yet reported Eisai Inc. 90 participants Est. completion 2010-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01159145

    Study to Assess the Pharmacodynamics/Pharmacokinetics After Repeated Dosing of D961H 10 mg and Omeprazole 10 mg in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 42 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Pharmacodynamics Study
    View official trial listing →
  • Completed NCT NCT01170169

    Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 44 participants Est. completion 2006-03 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01170182

    Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fed Condition

    Not yet reported Dr. Reddy's Laboratories Limited 54 participants Est. completion 2006-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01170533

    PPI and Clopidogrel Response

    Not yet reported University of Florida 20 participants Est. completion 2010-08 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT01187862

    Pharmacokinetic Study to Investigate Low-dose Combinations of a Cocktail of Seven Drugs for Simultaneous Phenotyping of Cytochromes

    Not yet reported University Hospital, Basel, Switzerland 16 participants 1 site
    Other conditions: Cytochrome, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01188525

    Pharmacokinetic Study to Characterize Individual Metabolic Profile

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 10 participants Est. completion 2011-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01199328

    Study to Evaluate the Interaction Between Aspirin and Nexium

    Not yet reported AstraZeneca 34 participants Est. completion 2010-11 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01205087

    Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome

    Not yet reported Hadassah Medical Organization 36 participants Est. completion 2011-04 1 site
    MASH
    View official trial listing →
  • Completed NCT NCT01209104

    Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors

    Not yet reported GlaxoSmithKline 32 participants Est. completion 2010-05-24 1 site
    Other conditions: Nutritional Status
    View official trial listing →
  • Completed NCT NCT01216293

    Effect of Dexlansoprazole on Bone Homeostasis

    Not yet reported Takeda 115 participants Est. completion 2015-02-01 12 sites
    Other conditions: Homeostasis, Bone and Bones
    View official trial listing →
  • Completed NCT NCT01218620

    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 17 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Adult Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT01249651

    To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

    Not yet reported AstraZeneca 101 participants Est. completion 2011-06 1 site
    Other conditions: Heartburn
    View official trial listing →
  • Withdrawn NCT NCT01260844

    Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Interaction of Briakinumab on CYP Substrates.

    Not yet reported Abbott 12 participants
    Other conditions: Moderate to Severe Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01265550

    A Randomized Trial of Medical and Surgical Treatments for Patients With GERD Symptoms That Are Refractory to Proton Pump Inhibitors

    Not yet reported VA Office of Research and Development 366 participants Est. completion 2016-12-30 15 sites
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT01269333

    Impact of Omeprazole and Fluvoxamine on Platelet Response to Clopidogrel

    Not yet reported Hadassah Medical Organization 15 participants 1 site Stand-alone
    Other conditions: Drug Interaction of Clopidogrel
    View official trial listing →
  • Completed NCT NCT01269788

    Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical Trial

    Not yet reported, Not yet reported Tehran University of Medical Sciences 144 participants Est. completion 2011-08 1 site
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT01275170

    A Single-Dose Study to Investigate the Pharmacokinetics of MK-7655 in Participants With Impaired Renal Function (MK-7655-005)

    Not yet reported Merck Sharp & Dohme LLC 49 participants Est. completion 2012-03-05 Stand-alone
    Other conditions: Infectious Disease
    View official trial listing →
  • Status unknown NCT NCT01275937

    A Double Blind Study Comparing Two Doses of IV Esomeprazole After Successful Endoscopic Therapy

    Not yet reported Taipei Medical University 65 participants Est. completion 2014-01 1 site
    Other conditions: Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT01287195

    Oral OKT3 for the Treatment of Active Ulcerative Colitis

    Not yet reported, Not yet reported Brigham and Women's Hospital 6 participants Est. completion 2013-05-02 1 site Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01287598

    BAY73-4506 Probe Substrate Study

    Not yet reported Bayer 41 participants Est. completion 2018-07-30 4 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT01290380

    A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Novartis Pharmaceuticals 54 participants 2 sites Stand-alone
    Other conditions: Solid Tumor Malignancies
    View official trial listing →
  • Completed NCT NCT01303445

    Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers

    Not yet reported Boehringer Ingelheim 60 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01323465

    Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

    Not yet reported Jazz Pharmaceuticals 36 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4, Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor
    View official trial listing →
  • Status unknown NCT NCT01335334

    H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

    Not yet reported The University of Texas Health Science Center, Houston 50 participants Est. completion 2011-08 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT01337804

    A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

    Not yet reported Bayer 50 participants Est. completion 2011-01 Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01338077

    Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease

    Not yet reported Chang Gung Memorial Hospital 195 participants Est. completion 2012-01 1 site
    Other conditions: Gastroesophageal Reflux Disease, Heartburn
    View official trial listing →
  • Completed NCT NCT01341600

    Clopidogrel Pharmacogenetics (PGX) Bench to Bedside

    Not yet reported University of Maryland, Baltimore 18 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Metabolism of Clopidogrel
    View official trial listing →
  • Completed NCT NCT01349413

    BRAVO Study for Functional Dyspepsia

    Not yet reported Chinese University of Hong Kong 130 participants Est. completion 2018-07-19 1 site
    Other conditions: Dyspepsia, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01358383

    Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

    Not yet reported AstraZeneca 28 participants Est. completion 2011-06 1 site
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT01361217

    The Effects of Multiple Dose Fluoxetine and Metabolites on CYP1A2, CYP2C19, CYP2D6 and CYP3A4 Activity

    Not yet reported University of Washington 10 participants Est. completion 2012-06 Stand-alone
    Other conditions: Drug-Drug Interaction, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01370525

    Efficacy of Esomeprazole in Patients With Frequent Heartburn

    Not yet reported AstraZeneca 340 participants Est. completion 2011-10 10 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01370538

    Efficacy of Esomeprazole in Patients With Frequent Heartburn

    Not yet reported AstraZeneca 341 participants Est. completion 2011-10 10 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01389401

    Salivary Epidermal Growth Factor (EGF) Concentration Before and After Treatment of Reflux Laryngitis

    Faculdade de Ciências Médicas da Santa Casa de São Paulo 36 participants Est. completion 2011-07 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD), Chronic Laryngitis
    View official trial listing →
  • Completed NCT NCT01392755

    A Study to Evaluate The Effects of Two Different Meal Types, Omeprazole And Ranitidine On Danoprevir Pharmacokinetics When Coadministered With Ritonavir in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 32 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01397084

    To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole

    Not yet reported AstraZeneca 107 participants Est. completion 2012-01
    Other conditions: Gastroesophageal Reflux Disease, GERD, Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01399047

    Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis

    Not yet reported University of Rochester 19 participants Est. completion 2015-11 1 site
    Other conditions: Juvenile Neuronal Ceroid Lipofuscinosis
    View official trial listing →
  • Terminated NCT NCT01408849

    Use of Maytenus Ilicifolia in the Treatment of Dyspepsia

    Not yet reported Casa Espirita Terra de Ismael 4 participants Est. completion 2016-01 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT01415128

    Compare the Pharmacokinetics of Omeprazole, Rosiglitazone, and Desipramine When Administered With Avanafil in Healthy Male Subjects

    Not yet reported VIVUS LLC 60 participants Est. completion 2010-05
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT01415349

    SSP-002358 Drug Interaction Study With Omeprazole

    Not yet reported Shire 42 participants Est. completion 2011-09-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01434485

    Nexium Capsules Clinical Experience Investigation

    AstraZeneca 3691 participants Est. completion 2014-03 47 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome
    View official trial listing →
  • Completed NCT NCT01435525

    Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation

    AstraZeneca 369 participants Est. completion 2014-03 36 sites
    Obstructive sleep apnea Other conditions: Gastric Ulcer, Duodenal Ulcer, Lymphoma Idiopathic Thrombocytopenic Purpura, Early Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01448031

    A Healthy Female and Male Volunteers Aspirin Study

    Not yet reported AstraZeneca 54 participants Est. completion 2012-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01452906

    A Drug-Drug Interaction Study of Omeprazole and PA21

    Not yet reported Vifor Pharma 45 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01456273

    From the Biomedical to the Biopsychosocial Model, From Theory to Practice

    Not yet reported Faculdade de Medicina do ABC 200 participants Est. completion 2011-12 1 site
    Other conditions: Functional Dyspepsia
    View official trial listing →
  • Completed NCT NCT01456728

    Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors

    Not yet reported St Marina University Hospital, Varna, Bulgaria 56 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01458054

    Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults

    Not yet reported GlaxoSmithKline 28 participants Est. completion 2011-11-28 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01458990

    Proton Pump Inhibitors and Dysbiosis in Cirrhosis

    Not yet reported Hunter Holmes Mcguire Veteran Affairs Medical Center 60 participants Est. completion 2018-02 1 site Stand-alone
    Other conditions: Cirrhosis, Healthy
    View official trial listing →
  • Status unknown NCT NCT01459419

    Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects

    Not yet reported Inspira Medical AB 36 participants Est. completion 2013-10 2 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT01462318

    An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

    Not yet reported Biogen 133 participants Est. completion 2016-01 19 sites Stand-alone
    Other conditions: Relapsing-Remitting Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT01464060

    14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication

    Not yet reported Infante, Javier Molina, M.D. 400 participants Est. completion 2013-01 4 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01465113

    Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus

    Not yet reported Case Comprehensive Cancer Center 26 participants Est. completion 2016-02 3 sites Stand-alone
    Other conditions: Short Segment Barrett's Esophagus, Long Segment Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT01470690

    Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: HCV Infections, Gastric Acid-related Disorders
    View official trial listing →
  • Withdrawn NCT NCT01471925

    Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

    Not yet reported Eurofarma Laboratorios S.A. 6 sites
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01473173

    Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 59 participants Est. completion 2012-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01486082

    Antimicrobial Susceptibility for Helicobacter Pylori Eradication

    Hospital Donostia 1 participants Est. completion 2012-05 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01489943

    A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2011-11-10 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01493089

    Phase III Study Comparing Zegerid® With Losec® for the Relief of Heartburn Associated With Gastroesophageal Reflux Disease

    Not yet reported Norgine 239 participants Est. completion 2011-10 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT01494402

    Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 77 participants Est. completion 2012-03 1 site
    Other conditions: Bioequivalence Study
    View official trial listing →
  • Completed NCT NCT01499368

    A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients

    Not yet reported Boryung Pharmaceutical Co., Ltd 495 participants Est. completion 2012-11
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT01507792

    Iron Repletion in Chronic Cough and Iron Deficiency

    Not yet reported University of Turin, Italy 22 participants Est. completion 2011-01 1 site
    Other conditions: Cough, Laryngeal Disease, Bronchial Disease, Iron Deficiency
    View official trial listing →
  • Completed NCT NCT01510730

    Helicobacter Pylori Eradication After Endoscopic Resection of Gastric Tumors

    Not yet reported Seoul National University Hospital 855 participants Est. completion 2011-02 1 site
    Other conditions: Gastric Tumor, Helicobacter Pylori, Endoscopic Resection, Metachronous Neoplasms
    View official trial listing →
  • Completed NCT NCT01517399

    Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

    Not yet reported Daiichi Sankyo 28 participants Est. completion 2013-09 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT01538849

    Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis

    Not yet reported Yuhan Corporation 154 participants Est. completion 2014-05 1 site
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01539655

    Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of Vandetanib

    Not yet reported Sanofi 34 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Medullary Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT01544114

    A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA)

    Not yet reported Amgen 46 participants Est. completion 2015-02 17 sites
    Other conditions: Juvenile Idiopathic Arthritis (JIA)
    View official trial listing →
  • Completed NCT NCT01544517

    5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection

    Not yet reported University of Campania Luigi Vanvitelli 180 participants Est. completion 2011-12 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01549574

    Drug Drug Interaction Study Of Crizotinib With Esomeprazole.

    Not yet reported Pfizer 16 participants Est. completion 2012-05 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01557335

    A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

    Not yet reported POZEN 30 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Platelet Aggregation
    View official trial listing →
  • Completed NCT NCT01562600

    Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation

    AstraZeneca 1634 participants Est. completion 2015-08-27 46 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT01562639

    Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

    AstraZeneca 647 participants Est. completion 2014-07 46 sites
    Other conditions: Repeatedly Recurring Esophagitis, Relapsing Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01566474

    Melatonin Associated to Acid Inhibition for Chemoprevention in Barret Esophagus: a Pilot Study

    Not yet reported Aragon Institute of Health Sciences 80 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Barrett's Esophagus
    View official trial listing →
  • Completed NCT NCT01570569

    Development of Minidose Inje Cocktail Method for Simultaneous Evaluating Five Cytochrome P450 Isoforms in Human

    Not yet reported Inje University 26 participants Est. completion 2011-03
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01579539

    The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy

    Not yet reported Medical University of Vienna 18 participants Est. completion 2017-05-18 1 site
    Other conditions: Thyroid-associated Ophthalmopathy, Dry Eye Syndrome
    View official trial listing →
  • Completed NCT NCT01585623

    Drug Interaction Study of SAR302503 in Patients With Solid Tumor

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2013-03 3 sites
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT01587885

    Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

    Not yet reported Bayer 48 participants Est. completion 2012-05 Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT01591083

    The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers

    Not yet reported National Cheng-Kung University Hospital 474 participants Est. completion 2014-07 1 site
    Other conditions: Peptic Ulcer Bleeding
    View official trial listing →
  • Completed NCT NCT01593592

    Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients

    Not yet reported Zagazig University 70 participants 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01595425

    Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 71 participants Est. completion 2012-06 1 site
    Other conditions: Bioequivalence Study
    View official trial listing →
  • Completed NCT NCT01596647

    Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors

    Not yet reported Novartis Pharmaceuticals 39 participants Est. completion 2014-07 5 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Excluding Breast Cancer
    View official trial listing →
  • Completed NCT NCT01599858

    Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers

    Not yet reported Trio Medicines Ltd. 49 participants Est. completion 1996-10 1 site
    Other conditions: Reflux Oesophagitis
    View official trial listing →
  • Completed NCT NCT01636557

    A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis

    Not yet reported Janssen Research & Development, LLC 12 participants Est. completion 2013-10-19 5 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Terminated NCT NCT01643785

    Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP Infection

    Not yet reported Chuncheon Sacred Heart Hospital 30 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01654549

    Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis

    Not yet reported Tehran University of Medical Sciences 40 participants Est. completion 2012-09 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01657578

    Optimal Dosing of Omeprazole in Neonates

    Not yet reported Assistance Publique - Hôpitaux de Paris 55 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT01661101

    Management of Myocardial Injury After Noncardiac Surgery Trial

    Not yet reported Population Health Research Institute 1754 participants Est. completion 2018-03-01 82 sites Stand-alone
    Other conditions: Myocardial Injury After Noncardiac Surgery (MINS)
    View official trial listing →
  • Completed NCT NCT01667575

    Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori

    Not yet reported Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2013-05 1 site
    Other conditions: Functional Dyspepsia, Peptic Ulcer, Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT01669811

    Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)

    Not yet reported AstraZeneca 1398 participants Est. completion 2014-05 63 sites
    Other conditions: Refractory Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT01670552

    Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients

    Not yet reported EMS 490 participants Est. completion 2017-03-17 1 site
    Other conditions: Acute and Chronic Inflammation, Dyspepsia
    View official trial listing →
  • Withdrawn NCT NCT01678053

    Efficacy Study of Botulinum Toxin (BOTOX) Injections to Treat Vocal Fold Granulomas

    Not yet reported Phillip Song, MD Est. completion 2015-01 1 site Stand-alone
    Other conditions: Contact Ulcer of Vocal Folds, Granuloma of Vocal Cords, Granuloma, Laryngeal, Granuloma
    View official trial listing →
  • Completed NCT NCT01694706

    Investigation of Food Effect and Gastric ph Increase on the Bioavailability of Faldapravir

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01710800

    Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy

    Not yet reported Walter Reed National Military Medical Center 41 participants Est. completion 2012-09
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT01710995

    A Three-Period Study to Investigate the Relative Bioavailability and Pharmacodynamic Profiles of a Zegerid 20mg Capsule, Zegerid 20mg Powder for Oral Suspension and Losec 20mg Capsule in Healthy Adult Volunteers Under Fasting Conditions

    Not yet reported Norgine 20 participants Est. completion 2011-02 1 site
    Other conditions: Acid Reflux, Gastro Oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01711320

    Effect of Omeprazole on Metformin

    Not yet reported Xijing Hospital 20 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01712711

    Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease

    Not yet reported Tehran University of Medical Sciences 40 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Status unknown NCT NCT01723059

    Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

    Not yet reported Dallas VA Medical Center 184 participants Est. completion 2013-01 1 site
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Status unknown NCT NCT01725906

    Genotypic Resistance Guided Therapy in Helicobacter Pylori Eradication

    Not yet reported National Taiwan University Hospital 450 participants Est. completion 2017-12 2 sites
    Other conditions: Self Efficacy
    View official trial listing →
  • Completed NCT NCT01729182

    Nexium Capsules LDA Specific Clinical Experience Investigation

    AstraZeneca 2363 participants Est. completion 2017-03-09 47 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Completed NCT NCT01731067

    Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot

    Not yet reported Jules Desmeules 10 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT01735227

    Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)

    Not yet reported Yaling Han 620 participants Est. completion 2013-10 2 sites Stand-alone
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Completed NCT NCT01750437

    Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)

    Not yet reported Yuhan Corporation 149 participants Est. completion 2014-04 10 sites
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT01755221

    Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR

    Northwestern University 42 participants Est. completion 2016-08 1 site
    Other conditions: Laryngopharyngeal Reflux (LPR), Extraesophageal Reflux, Reflux Laryngitis, Posterior Laryngitis
    View official trial listing →
  • Completed NCT NCT01757275

    High Dose Esomeprazole Na for Prevention of Rebleeding After Successful Endoscopic Therapy of a Bleeding Peptic Ulcer

    Not yet reported AstraZeneca 239 participants Est. completion 2014-12 12 sites
    Other conditions: Bleeding Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT01759628

    Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver Disease

    Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT01760824

    Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication

    Not yet reported The University of Hong Kong 391 participants Est. completion 2012-12 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01761513

    YH4808 Postprandial PK/PD Study in Healthy Subjects

    Not yet reported Yuhan Corporation 21 participants Est. completion 2014-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT01762644

    The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients

    Not yet reported Perle Bioscience, Inc. Est. completion 2016-08 Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01766050

    Study to Evaluate Effect of Belatacept on Pharmacokinetics of Inje Cocktail in Healthy Volunteers

    Not yet reported Bristol-Myers Squibb 45 participants Est. completion 2013-04 1 site Stand-alone
    Other conditions: Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT01777854

    Anti-reflux Control to Decrease Post Tonsillectomy Pain

    Not yet reported Ascension Health 6 participants Est. completion 2015-07 1 site
    Other conditions: Laryngopharyngeal Reflux, Throat Pain
    View official trial listing →
  • Withdrawn NCT NCT01782560

    Laryngomalacia Study

    Not yet reported Children's & Women's Health Centre of British Columbia Est. completion 2015-07 1 site
    Other conditions: Laryngomalacia
    View official trial listing →
  • Completed NCT NCT01786382

    A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole

    Not yet reported Presidio Pharmaceuticals, Inc. 24 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Pharmacokinetic Assessments in Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01792700

    Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

    Not yet reported Seoul National University Bundang Hospital 648 participants Est. completion 2010-12 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Status unknown NCT NCT01795794

    Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC

    Not yet reported Soroka University Medical Center 12 participants Est. completion 2013-12 Stand-alone
    Other conditions: CDA Type I
    View official trial listing →
  • Completed NCT NCT01813552

    To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

    Not yet reported Merck Sharp & Dohme LLC 24 participants Est. completion 2013-03 Stand-alone
    Other conditions: Chronic Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT01820143

    Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

    Not yet reported Il-Yang Pharm. Co., Ltd. 40 participants Est. completion 2005-04 1 site
    Other conditions: Healthy, Pharmacokinetics, Pharmacodynamics, Ilaprazole
    View official trial listing →
  • Status unknown NCT NCT01822106

    Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Wu-Chu-Yu Tang on Gastroesophageal Reflux Disease (GERD)

    Not yet reported China Medical University Hospital 90 participants 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT01822600

    The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia

    Not yet reported National Cheng-Kung University Hospital 91 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Peptic Ulcer Bleeding, Hypoalbuminemia
    View official trial listing →
  • Completed NCT NCT01822977

    The Impact of Proton Pump Inhibitors on the Fecal Microbiome

    Not yet reported Mayo Clinic 15 participants Est. completion 2013-12 1 site
    Other conditions: Healthy, Clostridium Difficile Infection
    View official trial listing →
  • Withdrawn NCT NCT01824199

    CYP2C19 Genotype Predictor of Gastric Acid Suppression

    Not yet reported Mayo Clinic Est. completion 2016-11 1 site Stand-alone
    Other conditions: Esophagitis
    View official trial listing →
  • Completed NCT NCT01841489

    A Phase 1 Study of Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics

    Not yet reported Gilead Sciences 56 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01844583

    Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib

    Not yet reported Millennium Pharmaceuticals, Inc. 55 participants Est. completion 2016-09-06 7 sites
    Other conditions: Solid Tumors, Lymphoma
    View official trial listing →
  • Completed NCT NCT01851863

    Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

    Not yet reported RenJi Hospital 262 participants Est. completion 2014-06 1 site
    Other conditions: Dyspepsia, Compliance, Depression
    View official trial listing →
  • Completed NCT NCT01854970

    Benefit of Pharyngeal and Oesophageal pH-impedance of Patients With High Suspicion of Laryngopharyngeal Reflux

    Not yet reported University Hospital, Bordeaux 30 participants Est. completion 2015-07 1 site
    Other conditions: Laryngopharyngeal Reflux, Oesophageal pH-impedance
    View official trial listing →
  • Completed NCT NCT01873079

    PPI for Prevention of Post-sphincterotomy Bleeding

    Not yet reported The University of Hong Kong 185 participants Est. completion 2016-06 1 site
    Other conditions: Bleeding, ERCP
    View official trial listing →
  • Completed NCT NCT01874535

    Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy

    Not yet reported Chang Gung Memorial Hospital 408 participants Est. completion 2016-06 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT01876108

    The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

    Not yet reported Tehran University of Medical Sciences 100 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Fatty Liver, Liver Dysfunction, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT01878526

    Gastroesophageal Reflux Treatment in Scleroderma

    Not yet reported Khon Kaen University 80 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease, Systemic Sclerosis, Scleroderma
    View official trial listing →
  • Completed NCT NCT01887249

    15-day Sequential Therapy for Helicobacter Pylori Infection in Korea

    Not yet reported Seoul National University Bundang Hospital 287 participants Est. completion 2013-07 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT01896557

    Ranitidin Versus Omeprazole in Patients Taking Clopidogrel

    Not yet reported University of Sao Paulo General Hospital 92 participants Est. completion 2013-06 Stand-alone
    Cardiovascular disease Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Completed NCT NCT01901276

    Effects of Gastric Acid on Colonic Microbiome

    Not yet reported Daniel Freedberg, MD 14 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Completed NCT NCT01907633

    An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide

    Janssen Research & Development, LLC 15000 participants Est. completion 2013-12
    Substance use disorder
    View official trial listing →
  • Completed NCT NCT01911728

    Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

    Not yet reported Astellas Pharma Europe B.V. 14 participants Est. completion 2012-02-21 2 sites Stand-alone
    Other conditions: Pharmacokinetics of MDV3100, Castration Resistant Prostate Cancer (CRPC)
    View official trial listing →
  • Completed NCT NCT01921647

    The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

    Not yet reported Yuhan Corporation 95 participants Est. completion 2013-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01921920

    Prilosec Bioequivalence Study in Healthy Volunteers

    Not yet reported AstraZeneca 54 participants Est. completion 2013-11 1 site
    Other conditions: Bioequivalence, AUC, Cmax, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT01922505

    Eradication Rates of Helicobacter Pylori and Its Affecting Factors

    Seoul National University Bundang Hospital 2500 participants Est. completion 2013-05 1 site
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT01925144

    A Study of Baricitinib and Omeprazole in Healthy Participants

    Not yet reported Eli Lilly and Company 30 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01934569

    Drug-Drug Interaction Study With PF-05089771

    Not yet reported Pfizer 17 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01938534

    Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use

    Not yet reported Ajou University School of Medicine 440 participants 1 site Stand-alone
    Other conditions: Helicobacter Eradication
    View official trial listing →
  • Completed NCT NCT01964131

    BE Study Between a Capsule and a Sachet Formulation of D961H by Pharmacodynamics in Japanese Healthy Male Subjects

    Not yet reported AstraZeneca 34 participants Est. completion 2013-12 2 sites
    Other conditions: Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Esophagitis, Etc.
    View official trial listing →
  • Completed NCT NCT01980095

    ERADICATE Hp - Treating Helicobacter Pylori With RHB-105

    Not yet reported RedHill Biopharma Limited 119 participants Est. completion 2015-08 12 sites Stand-alone
    Other conditions: Dyspepsia, Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT01983566

    Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese Subjects

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01983774

    Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations

    Not yet reported Columbia University 21 participants Est. completion 2011-08 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT02004197

    Quadruple and Phytomedicine-based Therapies in H. Pylori Infection

    Not yet reported, Not yet reported Hafiz Muhammad Asif 176 participants Est. completion 2013-01 2 sites
    Other conditions: Helicobacter Pylori [H. Pylori] as the Cause of Diseases
    View official trial listing →
  • Completed NCT NCT02013427

    Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial

    Not yet reported Northwestern University 82 participants Est. completion 2016-05 1 site
    Other conditions: Chronic Low Back Pain
    View official trial listing →
  • Withdrawn NCT NCT02013453

    A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

    Not yet reported University of Michigan Rogel Cancer Center 1 site Stand-alone
    Other conditions: Cancer of Head and Neck
    View official trial listing →
  • Terminated NCT NCT02016820

    Effect of Acid Suppression Medication on Pediatric Microbiome

    Not yet reported Columbia University 7 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Clostridium Difficile Infection
    View official trial listing →
  • Completed NCT NCT02023125

    A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers.

    Not yet reported Hoffmann-La Roche 42 participants Est. completion 2014-03 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT02028234

    "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-

    Not yet reported University of Roma La Sapienza 150 participants Est. completion 2016-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02028663

    Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

    Not yet reported HK inno.N Corporation 206 participants Est. completion 2014-05 1 site
    Other conditions: Erosive Esophagitis, GERD
    View official trial listing →
  • Completed NCT NCT02037477

    Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)

    Not yet reported Takeda 20 participants Est. completion 2014-03 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Withdrawn NCT NCT02039869

    Confocal Endomicroscopy for Non-Erosive Reflux Disease (CE NERD)

    Not yet reported Virginia Commonwealth University 3 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease, Non Erosive Reflux Disease, Dyspepsia
    View official trial listing →
  • Completed NCT NCT02045966

    Study to Determine the Potential DDIs When the Daclatasvir/Asunaprevir/BMS-791325 Three Drug Antiviral Combination Tablet (FDC) is Coadministered With a Cocktail of Cytochrome P450 (CYP) Probe Substrates and Transporter Probe Substrates (Digoxin and Pravastatin) in Healthy Subjects

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2014-04 Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT02056743

    Clinical Trials on Evaluate the Red Ginseng and Fermented-Red Ginseng Affect to Drug Metabolizing Enzyme and Transporter in Healthy Volunteers

    Not yet reported Chonbuk National University Hospital 30 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02071316

    The Use of Hexacapron in Upper Gastrointestinal Bleeding

    Not yet reported Shaare Zedek Medical Center 300 participants Est. completion 2015-04 1 site
    Other conditions: Upper Gastrointestinal Bleeding, Hexacapron, Hemostasis, Rebleeding, Mortality
    View official trial listing →
  • Completed NCT NCT02081404

    Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study

    Not yet reported Midwest Biomedical Research 98 participants Est. completion 2020-08-05 2 sites
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT02085018

    Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF)

    Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 45 participants Est. completion 2016-09-27 1 site Stand-alone
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Withdrawn NCT NCT02090738

    A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide

    Not yet reported Yonsei University 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Completed NCT NCT02108704

    Helicobacter Pylori Eradication Study in Parkinson's Disease

    Not yet reported University of Malaya 75 participants Est. completion 2016-05 1 site
    Other conditions: Parkinson's Disease, Helicobacter Pylori Infection
    View official trial listing →
  • Withdrawn NCT NCT02123498

    The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux

    Not yet reported Loma Linda University 2 sites Stand-alone
    Other conditions: Eustachian Tube Dysfunction, Laryngopharyngeal Reflux
    View official trial listing →
  • Completed NCT NCT02128893

    A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of Isavuconazole

    Not yet reported Astellas Pharma Global Development, Inc. 24 participants Est. completion 2014-02 1 site
    Other conditions: Pharmacokinetics of Isavuconazole, Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT02134405

    Rebamipide in Combination With Esomeprazole in the Management of Asian Patients With Functional Dyspepsia

    Not yet reported University of Malaya 200 participants Est. completion 2016-12 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT02140073

    Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate Severity

    Not yet reported Belarusian Medical Academy of Post-Graduate Education 60 participants Est. completion 2014-06 2 sites Stand-alone
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT02141698

    Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese Subjects

    Not yet reported Takeda 73 participants Est. completion 2008-02
    Other conditions: Dose Finding Study
    View official trial listing →
  • Withdrawn NCT NCT02153177

    The Effect of NSAIDs After a Rotator Cuff Repair Surgery.

    Not yet reported University of Chicago Est. completion 2018-12 1 site
    Other conditions: Rotator Cuff Tear
    View official trial listing →
  • Completed NCT NCT02157376

    Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients

    Not yet reported AstraZeneca 343 participants Est. completion 2016-02 15 sites
    Other conditions: Stress Ulcer Prophylaxis
    View official trial listing →
  • Completed NCT NCT02182336

    Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 23 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02190708

    Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole

    Not yet reported Vivoryon Therapeutics N.V. 18 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Healthy Volunteers, Pharmacologic Action
    View official trial listing →
  • Completed NCT NCT02191358

    YouScript IMPACT Registry

    Genelex Corporation 800 participants Est. completion 2015-08 7 sites
    Other conditions: Adverse Drug Events, Adverse Drug Reactions, Drug Interaction Potentiation, Drug Metabolism, Poor, CYP2D6-RELATED, Drug Metabolism, Poor, CYP2C19-RELATED, Cytochrome P450 Enzyme Deficiency, Cytochrome P450 CYP2D6 Enzyme Deficiency, Cytochrome P450 CYP2C9 Enzyme Deficiency, Cytochrome P450 CYP2C19 Enzyme Deficiency, Cytochrome P450 CYP3A Enzyme Deficiency, Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant, Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
    View official trial listing →
  • Completed NCT NCT02197039

    The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers

    National Cheng-Kung University Hospital 316 participants Est. completion 2014-07 1 site
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT02197143

    A Comparison of Efficacy of Intravenous Esomeprazole and Ranitidine Treatment of Dyspeptic Pain

    Not yet reported Pamukkale University 286 participants Est. completion 2014-07 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT02199002

    Acid Pocket: Position and Aspiration

    Not yet reported KU Leuven 70 participants Est. completion 2017-12-31 1 site
    Other conditions: GERD - PPI Responders, GERD - PPI Non-responders, Barrett Esophagus, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02205489

    Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADA

    Not yet reported Genzyme, a Sanofi Company 58 participants Est. completion 2016-04 20 sites
    Other conditions: Relapsing-remitting Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT02220777

    A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized Males

    Not yet reported Astellas Pharma Europe B.V. 72 participants Est. completion 2011-05 2 sites Stand-alone
    Other conditions: Pharmacokinetics of ASP8477, Pharmacodynamics of ASP8477
    View official trial listing →
  • Completed NCT NCT02224053

    Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers

    Not yet reported AstraZeneca 136 participants Est. completion 2015-01 2 sites Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT02226783

    D5611C00003 - Food Interaction Study With AZD1722 Tablet in Healthy Subjects

    Not yet reported Ardelyx 37 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Healthy Volunteers Food Interaction Study
    View official trial listing →
  • Completed NCT NCT02229877

    A Study to Assess the Effect of Intragastric pH and Fasting on the Pharmacokinetics of Gefapixant (AF-219/MK-7264)

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 18 participants Est. completion 2015-05-22 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02243553

    Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 34 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02249871

    Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects

    Not yet reported Novo Nordisk A/S 54 participants Est. completion 2015-04-01 1 site Added to GLP-1
    Other conditions: Diabetes, Healthy
    View official trial listing →
  • Completed NCT NCT02249936

    A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations

    Not yet reported Ardelyx 18 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02253875

    Study to Determine the Effects of Multiple-dose Omeprazole on the Single-dose Pharmacokinetics of Tipranavir (TPV) Coadministered With Ritonavir (RTV) in Healthy Adult Volunteers

    Not yet reported Boehringer Ingelheim 15 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02254148

    The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)

    Not yet reported Boehringer Ingelheim 24 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02256813

    Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 20 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02262169

    DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers

    Not yet reported Dexa Medica Group 32 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Non-Bleeding Peptic Ulcers
    View official trial listing →
  • Terminated NCT NCT02272868

    Fecal Microbial Transplant in Pediatric Crohn's Disease

    Not yet reported, Not yet reported Seattle Children's Hospital 7 participants Est. completion 2016-10-01 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Status unknown NCT NCT02277886

    Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances

    Not yet reported Chang Gung Memorial Hospital 340 participants Est. completion 2016-06 1 site
    Other conditions: Gastroesophageal Reflux Disease, Heartburn, Sleep Disturbance
    View official trial listing →
  • Completed NCT NCT02278432

    Evaluation of the Prophylactic Use of Omeprazole in Patients Admitted to the State Hospital of Américo Brasiliense

    Universidade Estadual Paulista Júlio de Mesquita Filho 427 participants Est. completion 2015-10
    Other conditions: Omeprazole
    View official trial listing →
  • Status unknown NCT NCT02288078

    Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)

    Not yet reported Clinical Research Support Center Kyush 74 participants Est. completion 2016-09 1 site
    Other conditions: Rectal Cancer
    View official trial listing →
  • Completed NCT NCT02291666

    Evaluation of CYP450 Activities in Diabetic Patients vs. Non-diabetic Subjects

    Not yet reported Centre hospitalier de l'Université de Montréal (CHUM) 73 participants Est. completion 2019-07 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02296021

    Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 612 participants Est. completion 2015-09 1 site
    Other conditions: Gastritis, Peptic Ulcer, Dyspepsia
    View official trial listing →
  • Completed NCT NCT02297126

    A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

    Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 site
    Other conditions: Adverse Drug Reaction
    View official trial listing →
  • Completed NCT NCT02299687

    Influence of CYP2C19 Polymorphism on PK/PD of Omeprazole

    Not yet reported Seoul National University Hospital 24 participants 1 site Stand-alone
    Other conditions: Stomach Ulcer
    View official trial listing →
  • Status unknown NCT NCT02307305

    Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?

    Not yet reported Hanyang University Seoul Hospital 168 participants Est. completion 2016-12 1 site
    Other conditions: Neuropathic Pain
    View official trial listing →
  • Withdrawn NCT NCT02307591

    Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

    Not yet reported, Not yet reported Emergency NGO Onlus Est. completion 2015-07
    Other conditions: Ebola Virus Disease
    View official trial listing →
  • Withdrawn NCT NCT02345304

    Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim Est. completion 2015-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02355236

    Gastro-protective Effect and Pain Relief Effect of Naxozol Compared to Celecoxib in Patients With Osteoarthritis

    Not yet reported Severance Hospital 106 participants Est. completion 2015-12 10 sites
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02359604

    The Gastrointestinal Microbiome of Infants With GERD and PPI Therapy: a Pilot Study

    Not yet reported Medical University of Graz 12 participants Est. completion 2017-02-07 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02361619

    Dabigatran in an Interaction Probe Drug Cocktail

    Not yet reported Turku University Hospital 16 participants Est. completion 2017-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02365558

    A Study to Evaluate the Effect of Increased Stomach pH on Evacetrapib in Healthy Participants

    Not yet reported Eli Lilly and Company 34 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02367937

    PRC-4016 (Icosabutate) Phase I Drug-drug Interaction Study

    Not yet reported Pronova BioPharma 16 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02391688

    Evaluation of the Potential Pharmacokinetic Interactions Between Probe Drugs in the Geneva Phenotyping Cocktail

    Not yet reported Jules Desmeules 30 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT02394340

    Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris

    Not yet reported Bausch & Lomb Incorporated 20 participants Est. completion 2015-04-01 1 site Stand-alone
    Other conditions: Tinea Pedis, Tinea Cruris
    View official trial listing →
  • Completed NCT NCT02395458

    Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens

    Not yet reported Coordinación de Investigación en Salud, Mexico 142 participants Est. completion 2015-02 Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT02397382

    Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

    Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2016-08-31 8 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Active, not recruiting NCT NCT02407119

    Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD

    Not yet reported National Cancer Center, Korea 470 participants Est. completion 2030-06 1 site
    Other conditions: Helicobacter Pylori Infection, Early Gastric Cancer, Endoscopic Resection
    View official trial listing →
  • Status unknown NCT NCT02422706

    Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

    Not yet reported Sherief Abd-Elsalam 120 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Helicobacter-associated Gastritis
    View official trial listing →
  • Completed NCT NCT02433457

    Relative Bioavailability Study of CC-292

    Not yet reported Celgene 24 participants Est. completion 2014-09-26 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02434861

    An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects

    Not yet reported Tesaro, Inc. 102 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Chemotherapy-induced Nausea and Vomiting
    View official trial listing →
  • Status unknown NCT NCT02438072

    Drug Metabolism and Antidepressant

    Not yet reported University Hospital, Geneva 100 participants Est. completion 2015-12 1 site
    Other conditions: Depression
    View official trial listing →
  • Status unknown NCT NCT02444507

    A Pharmacokinetic Study to Evaluate the Bioequivalence of a Test Formulation Compared to an Equivalent Dose of a Reference Drug Product

    Not yet reported isRed Pharma & Biotech Research Corporation 14 participants Est. completion 2015-06 1 site
    Other conditions: Healthy Adult Subjects
    View official trial listing →
  • Completed NCT NCT02453022

    A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole

    Not yet reported GlaxoSmithKline 18 participants Est. completion 2015-07-31 1 site Stand-alone
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02456012

    Long-term Oral Esomeprazole for Prevention of Peptic Ulcer Rebleeding in High-risk Patients

    Not yet reported Hsiu-Chi Cheng 268 participants Est. completion 2020-12-31 1 site
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT02456935

    Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

    Not yet reported HK inno.N Corporation 280 participants Est. completion 2016-09 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Status unknown NCT NCT02472600

    Eradication of Antibiotic-resistant Bacteria Through Antibiotics and Fecal Bacteriotherapy

    Not yet reported Stephen Harbarth 39 participants Est. completion 2018-03 4 sites
    Other conditions: Intestinal Colonization With Multidrug-resistant Bacteria
    View official trial listing →
  • Completed NCT NCT02473627

    A PHASE 1, OPEN-LABEL, CROSS-OVER, FIXED SEQUENCE STUDY TO EVALUATE THE EFFECT OF MULTIPLE DOSES OF DS-1971A ON THE SINGLE DOSE PHARMACOKINETICS OF PROBE SUBSTRATES FOR CYP2B6, CYP2C8, CYP2C9, CYP2C19 AND CYP3A4 ENZYMES IN HEALTHY MALE AND FEMALE SUBJECTS

    Not yet reported Daiichi Sankyo 18 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02473640

    A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an Ileostomy

    Not yet reported, Not yet reported Theriva Biologics, Inc. 15 participants Est. completion 2016-04 2 sites
    Other conditions: Healthy Volunteers With Ileostomy
    View official trial listing →
  • Terminated NCT NCT02475369

    Pancreatic Enzyme Supplementation for Celiac Disease

    Not yet reported Beth Israel Deaconess Medical Center 21 participants Est. completion 2019-12 1 site
    Other conditions: Celiac Disease
    View official trial listing →
  • Status unknown NCT NCT02476097

    PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms

    Not yet reported Victoria Rollason 58 participants Est. completion 2023-12 2 sites
    Other conditions: Stomach Diseases
    View official trial listing →
  • Completed NCT NCT02477475

    Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical Outcomes

    AstraZeneca 1595 participants Est. completion 2017-02-20 47 sites
    Other conditions: Reflux Esophagitis
    View official trial listing →
  • Completed NCT NCT02479581

    The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

    Not yet reported Xiangya Hospital of Central South University 226 participants Est. completion 2017-05 1 site
    Other conditions: Valvular Heart Disease
    View official trial listing →
  • Completed NCT NCT02486263

    Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial

    Not yet reported Sudarshan Jadcherla 76 participants Est. completion 2020-03-31 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02492776

    A Multiple-Dose Pharmacokinetics Study of Two Gefapixant (AF-219/MK-7264) Formulations

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 14 participants Est. completion 2015-08-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02494856

    Comparison of the Clinical Efficacy of Naproxen, Associated or Not With Esomeprazol, in Lower Third Molar Removal

    Not yet reported Giovana Maria Weckwerth 50 participants Est. completion 2016-03 1 site
    Other conditions: Pain, Other Surgical Procedures, Impacted Third Molar Tooth
    View official trial listing →
  • Completed NCT NCT02500641

    Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout

    Not yet reported Menarini International Operations Luxembourg SA 196 participants Est. completion 2017-05-10 26 sites Stand-alone
    Other conditions: Gout
    View official trial listing →
  • Completed NCT NCT02504554

    Beneficial Bacteria Treatment for Autism

    Not yet reported, Not yet reported Arizona State University 18 participants Est. completion 2016-04
    Other conditions: Gastrointestinal Problems, Autism Spectrum Disorders
    View official trial listing →
  • Completed NCT NCT02505945

    The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease

    Not yet reported Torax Medical Incorporated 152 participants Est. completion 2018-08 21 sites
    Other conditions: GERD Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02506634

    The Primary Symptoms of GERD(Gastroesophageal Reflux Disease) in Chinese Outpatients in Gastroenterology Department

    First Affiliated Hospital, Sun Yat-Sen University 374 participants Est. completion 2019-01 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02515526

    Effect of Acute Ethanol Consumption on The Activity of Major Cytochrome P450 Enzymes, NAT2 and P-glycoprotein

    Not yet reported University of Cologne 16 participants Est. completion 2015-08-27 1 site Stand-alone
    Other conditions: AOD Effects and Consequences
    View official trial listing →
  • Completed NCT NCT02518373

    Effect of G17DT in Patients With Stage II/III Colorectal Cancer

    Not yet reported Cancer Advances Inc. 22 participants Est. completion 2001-02 Stand-alone
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT02524210

    Effect of Inhibitors of the Proton Pump on Intestinal Transporters

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 12 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02530879

    Comparison of Voice Therapy and Antireflex Therapy in LPR

    Not yet reported Temple University Est. completion 2018-01 2 sites
    Other conditions: Laryngopharyngeal Reflux
    View official trial listing →
  • Completed NCT NCT02536989

    Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot

    Not yet reported Far Eastern Memorial Hospital 40 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Peptic Ulcer, Hemorrhage
    View official trial listing →
  • Completed NCT NCT02543606

    Bioequivalence of Two Formulations of Esomeprazole

    Not yet reported Yung Shin Pharm. Ind. Co., Ltd. 14 participants Est. completion 2015-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02547012

    Comparison of Two Rescue Therapies for Helicobacter Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 51 participants Est. completion 2017-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02552537

    iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions

    Not yet reported University of Zurich 44 participants Est. completion 2017-03 2 sites
    Other conditions: Food Allergy
    View official trial listing →
  • Withdrawn NCT NCT02552641

    Food Effect on the Eradication Rate of H. Pylori With Triple Therapy With Esomeprazole

    Not yet reported EMS Est. completion 2016-09 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT02553083

    High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection

    Not yet reported Rabin Medical Center 300 participants Est. completion 2021-12 1 site
    Other conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
    View official trial listing →
  • Completed NCT NCT02555852

    Proton Pump Inhibitors and Risk of Community-acquired Pneumonia

    Canadian Network for Observational Drug Effect Studies, CNODES 4238504 participants Est. completion 2012-02 1 site
    Other conditions: Gastroesophageal Reflux Disease (GERD), Community-acquired Pneumonia
    View official trial listing →
  • Completed NCT NCT02567682

    Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

    Not yet reported Global Blood Therapeutics 24 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02578277

    Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates

    Not yet reported ViiV Healthcare 59 participants Est. completion 2015-12-23 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT02584751

    GERD and Anti-Reflux Therapy Between Able-bodied and SCI Individuals

    Not yet reported James J. Peters Veterans Affairs Medical Center 110 participants 1 site Stand-alone
    Other conditions: Gastro Esophageal Reflux Disorder
    View official trial listing →
  • Completed NCT NCT02586636

    Impact of OCT1 on Metformin Tolerance

    Not yet reported NHS Tayside 61 participants Est. completion 2018-04-09 1 site
    Other conditions: Tolerance
    View official trial listing →
  • Status unknown NCT NCT02590185

    MetAbolism vaRiability of VEnLafaxine

    Not yet reported Assistance Publique - Hôpitaux de Paris 205 participants Est. completion 2020-04 2 sites Stand-alone
    Other conditions: Major Depressive Disorders
    View official trial listing →
  • Active, not recruiting NCT NCT02592317

    A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

    Not yet reported Aragon Pharmaceuticals, Inc. 23 participants Est. completion 2027-12-31 3 sites Stand-alone
    Other conditions: Prostatic Neoplasms, Castration-Resistant
    View official trial listing →
  • Completed NCT NCT02593448

    Influence of Cardiopulmonary Bypass, and Sevoflurane or Propofol Anesthesia, on Tissue Oxygen Saturation.

    Not yet reported Medical University of Gdansk 64 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: NIR Spectroscopy
    View official trial listing →
  • Completed NCT NCT02595372

    Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

    Not yet reported Kathy Miller 42 participants Est. completion 2021-03-01 9 sites Stand-alone
    Other conditions: Cancer of the Breast
    View official trial listing →
  • Completed NCT NCT02596620

    Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

    Not yet reported Chang Gung Memorial Hospital 164 participants Est. completion 2015-11
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02609386

    IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity

    Not yet reported Brooklyn ImmunoTherapeutics, LLC 105 participants Est. completion 2022-02-28 22 sites Stand-alone
    Other conditions: Squamous Cell Carcinoma of the Oral Cavity
    View official trial listing →
  • Completed NCT NCT02620696

    Effect of Netazepide on Omeprazole-induced Changes in Chromogranin A and Gastrin

    Not yet reported Trio Medicines Ltd. 48 participants Est. completion 2010-09
    Other conditions: ECL-cell Hyperplasia, Parietal-cell Hyperplasia, Rebound Hyperacidity, Dyspepsia
    View official trial listing →
  • Status unknown NCT NCT02621359

    A Two Week Nitazoxanidebased Quadruple Regimen

    Not yet reported Tanta University 100 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT02623296

    A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects

    Not yet reported Lakefront Biotherapeutics NV 14 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02623816

    Symptom Control Satisfaction With Proton Pump Inhibitor Regimen

    Not yet reported MetroHealth Medical Center 64 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Heartburn
    View official trial listing →
  • Withdrawn NCT NCT02624544

    Proton Pump Inhibitors Use in Patients With Psoriasis

    Not yet reported EMS Est. completion 2016-12
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02635191

    Tailored Therapy for Helicobacter Pylori in Children

    Not yet reported Beijing Children's Hospital 200 participants Est. completion 2016-07 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02637557

    A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

    Not yet reported Ironwood Pharmaceuticals, Inc. 282 participants Est. completion 2017-04-26 62 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02638116

    A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults

    Not yet reported Janssen Research & Development, LLC 20 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02647086

    Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

    Not yet reported Regeneron Pharmaceuticals 14 participants Est. completion 2016-07 5 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT02659683

    Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Esomeprazole Magnesium DR Capsules Under Fasting Conditions

    Not yet reported Torrent Pharmaceuticals Limited 54 participants Est. completion 2011-05
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT02663492

    Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients

    Not yet reported Tongji University 300 participants Est. completion 2016-12 1 site
    Other conditions: Non-Small Cell Lung Cancer, Lung Cancer
    View official trial listing →
  • Completed NCT NCT02670642

    Open, Randomised, Multi-center Study of on Demand Versus Continuous Esomeprazole Treatment in Patient With GERD

    Not yet reported AstraZeneca 877 participants Est. completion 2002-11 60 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02680119

    BE of Torrent's Esomeprazole Mg DR Capsules

    Not yet reported Torrent Pharmaceuticals Limited 56 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02680132

    Bioequivalence Study of Torrent Pharmaceutical Ltd's Esomeprazole Magnesium Delayed Release Capsules

    Not yet reported Torrent Pharmaceuticals Limited 56 participants Est. completion 2011-05
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02684799

    Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination

    Not yet reported Tobira Therapeutics, Inc. 48 participants Est. completion 2016-04-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02685150

    Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

    Not yet reported Chinese PLA General Hospital 157 participants Est. completion 2018-06 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease, Dyspepsia, Bile Reflux
    View official trial listing →
  • Completed NCT NCT02685436

    Role of Pepsin Assay in Wheezy Infants

    Not yet reported Mansoura University Children Hospital 52 participants Est. completion 2015-05
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT02689583

    A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection

    Not yet reported First Affiliated Hospital of Zhejiang University 3000 participants Stand-alone
    Other conditions: Gastritis, Gastric Ulcer
    View official trial listing →
  • Status unknown NCT NCT02693574

    Comparison Efficacy of 14-day Triple Therapy: Clarithromycin vs. Levofloxacin on Eradication of H. Pylori

    Not yet reported Damascus Hospital 74 participants Est. completion 2017-05-31 1 site
    Other conditions: Helicobacter Pylori Gastrointestinal Tract Infection
    View official trial listing →
  • Completed NCT NCT02703896

    Prophylaxis for Aspiration of Gastric Contents.

    Not yet reported King Saud University 1920 participants Est. completion 2015-12
    Other conditions: Pulmonary Aspiration of Gastric Contents
    View official trial listing →
  • Completed NCT NCT02708355

    Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment

    Not yet reported Pfizer 55 participants Est. completion 2016-04 2 sites
    Other conditions: Heartburn
    View official trial listing →
  • Completed NCT NCT02710994

    Pharmacodynamics and Safety of CDFR0209

    Not yet reported Ajou University School of Medicine 30 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Stomach Ulcer, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02711176

    Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

    Not yet reported Zahra Vahdat Shariatpanahi 212 participants Est. completion 2017-03-27 1 site
    Other conditions: Helicobacter Infection
    View official trial listing →
  • Withdrawn NCT NCT02724150

    Comparison of Low Against High Regimen of Proton Pump Inhibitors for Treatment of Acute Peptic Ulcer Bleeding

    Not yet reported Damascus Hospital Est. completion 2021-07 1 site Stand-alone
    Other conditions: Gastroduodenal Ulcer, Marginal Ulcer, Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT02730026

    Comparison of the Clinical Efficacy of Ketoprofen, Associated or Not With Omeprazole in Lower Third Molar Removal

    Not yet reported Luis Fernando Simoneti 50 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Pain, Other Surgical Procedures
    View official trial listing →
  • Completed NCT NCT02730533

    The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD

    Not yet reported Xijing Hospital of Digestive Diseases 74 participants Est. completion 2017-04 1 site
    Other conditions: Stomach Neoplasms
    View official trial listing →
  • Completed NCT NCT02732249

    Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 66 participants Est. completion 2017-09-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02740712

    Pharmacokinetic Drug-Drug Interaction Study of Rucaparib

    Not yet reported pharmaand GmbH 17 participants Est. completion 2019-09 3 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02743949

    Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)

    Not yet reported Takeda 256 participants Est. completion 2018-10-12 39 sites
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02757144

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 120 participants Est. completion 2017-02 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT02760615

    Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

    Not yet reported Takeda Est. completion 2020-08-01 2 sites Stand-alone
    Other conditions: Colitis, Ulcerative, Crohn Disease
    View official trial listing →
  • Completed NCT NCT02762123

    A Study to Assess the Effect of BMS-986142 on Pharmacokinetics (PK) of Probe Substrates

    Not yet reported Bristol-Myers Squibb 28 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02772601

    This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

    Not yet reported AbbVie 21 participants Est. completion 2017-09-22 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02783040

    Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

    Not yet reported Boehringer Ingelheim 13 participants Est. completion 2015-10-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT02788591

    Confocal Endomicroscopy for Non-Erosive Reflux Disease Detection

    Not yet reported LCMC Health 5 participants Est. completion 2021-06 2 sites
    Other conditions: Non-erosive Reflux Disease, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02789527

    Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations

    Not yet reported Estella S. Poloni 367 participants Est. completion 2017-04 4 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02790840

    A Multiple-Dose Pharmacokinetics Study of Three Gefapixant (AF-219/MK-7264) Formulations

    Not yet reported Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 32 participants Est. completion 2016-06-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02794844

    Implementation of PPI Medication PGX Testing

    Not yet reported Nemours Children's Clinic 28 participants Est. completion 2018-08-31 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT02800330

    The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib

    Not yet reported Erasmus Medical Center 31 participants Est. completion 2018-02 1 site
    Other conditions: Colorectal Neoplasms, Gastrointestinal Stromal Tumors
    View official trial listing →
  • Completed NCT NCT02803216

    Traditional Chinese Medicine Combined With Standard Triple Region for Eradication of Helicobacter Pylori

    Not yet reported, Not yet reported Xiyuan Hospital of China Academy of Chinese Medical Sciences 576 participants Est. completion 2016-04 Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02819102

    An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

    Not yet reported BioCryst Pharmaceuticals 20 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Hereditary Angioedema
    View official trial listing →
  • Terminated NCT NCT02840929

    Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents

    Not yet reported The University of Hong Kong 2 participants Est. completion 2017-09 2 sites
    Other conditions: OGD, Gastric Ulcer Induced by Anti-platelet Agent, Duodenal Ulcer Induced by Anti-platelet Agent
    View official trial listing →
  • Completed NCT NCT02844621

    Effect of Proton Pump Inhibitors on Gut Microbiota and Systemic Inflammation in Older Adults

    Not yet reported The University of Texas Health Science Center at San Antonio 25 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02860624

    Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 550 participants
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02884713

    Levofloxacin-Doxycycline for Helicobacter Pylori Eradication in Saudi Arabia

    Not yet reported King Faisal Specialist Hospital & Research Center 55 participants Est. completion 2014-04
    Other conditions: GASTRITIS
    View official trial listing →
  • Status unknown NCT NCT02892357

    Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease

    Not yet reported, Not yet reported Xiyuan Hospital of China Academy of Chinese Medical Sciences 204 participants Est. completion 2019-12 2 sites Stand-alone
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT02893709

    Factors Influencing the Human Gut Microbiome Profile in Multi-ethnic Groups of the Singapore Community (FAMES)

    Not yet reported Changi General Hospital 36 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT02894268

    Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored Therapy

    Not yet reported Sir Run Run Shaw Hospital 300 participants Est. completion 2019-12 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02922699

    Efficacy and Saafety of Omez Iin Patients With H.Pylori Associated Diseases

    Not yet reported Dr. Reddy's Laboratories Limited 120 participants Est. completion 2013-06 Stand-alone
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT02922933

    A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects

    Not yet reported Syndax Pharmaceuticals 66 participants Est. completion 2017-05-08 2 sites
    Other conditions: Volunteers, Healthy Volunteers, Human Volunteers, Normal Volunteers
    View official trial listing →
  • Completed NCT NCT02935010

    Tailored Versus Empiric Therapy for Helicobacter Pylori Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 382 participants Est. completion 2018-03-31 5 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02950259

    Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)

    Not yet reported Providence Health & Services 16 participants Est. completion 2025-09-25 1 site Stand-alone
    Other conditions: Breast Neoplasm, Breast Neoplasm, Male, Triple Negative Breast Cancer
    View official trial listing →
  • Completed NCT NCT02957474

    A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects

    Not yet reported Celgene 18 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02959255

    10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection

    Not yet reported Elpen Pharmaceutical Co. Inc. 364 participants Est. completion 2017-12-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT02978157

    Levofloxacin Triple and Bismuth Quadruple Therapies for Rescue Treatment of H Pylori Infection

    Not yet reported Kaohsiung Veterans General Hospital. 102 participants Est. completion 2017-09 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT02984930

    Effect of Proton Pump Inhibitor and Mosapride on Acid Pocket in Gastroesophageal Reflux Disease

    Not yet reported Gangnam Severance Hospital 30 participants Est. completion 2018-07
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT02986334

    Placebo In Chronic Back Pain (Phase 2)

    Not yet reported Apkar Apkarian 94 participants Est. completion 2018-06 1 site
    Other conditions: Chronic Low Back Pain
    View official trial listing →
  • Completed NCT NCT02993471

    A Study of Ixekizumab in Participants With Plaque Psoriasis

    Not yet reported Eli Lilly and Company 28 participants Est. completion 2017-11-21 3 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03006874

    Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

    Not yet reported HK inno.N Corporation 302 participants Est. completion 2017-03-24 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Withdrawn NCT NCT03021590

    Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.Pylori

    Not yet reported Damascus Hospital Est. completion 2022-01-31 1 site
    Other conditions: Helicobacter Pylori Gastrointestinal Tract Infection
    View official trial listing →
  • Completed NCT NCT03028103

    Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

    Not yet reported Epizyme, Inc. 32 participants Est. completion 2019-11-29 3 sites Stand-alone
    Other conditions: Diffuse Large B Cell Lymphoma, Primary Mediastinal Lymphoma, Mantle Cell Lymphoma, Advanced Solid Tumor, Marginal Zone Lymphoma
    View official trial listing →
  • Completed NCT NCT03033342

    Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4

    Not yet reported MicuRx 122 participants Est. completion 2017-02-01 Stand-alone
    Other conditions: Safety
    View official trial listing →
  • Status unknown NCT NCT03040817

    Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China

    Not yet reported Zhongda Hospital 50 participants Est. completion 2019-12-16 1 site
    Other conditions: Gastric Peroral Endoscopic Pyloromyotomy (G-POEM)
    View official trial listing →
  • Completed NCT NCT03058419

    A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects

    Not yet reported Janssen Research & Development, LLC 16 participants Est. completion 2017-05-15 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT03059303

    Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)

    Not yet reported Janssen Research & Development, LLC 72 participants Est. completion 2017-04-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03083639

    A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy Participants

    Not yet reported Takeda 52 participants Est. completion 2017-05-13 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT03086070

    Omeprazole 20 mg in Patients With Laryngopharyngeal reflux and Comorbid Chronic Rhinosinusitis

    Not yet reported Children's Hospital Srebrnjak 60 participants Est. completion 2010-06-30 Stand-alone
    Other conditions: Laryngopharyngeal Reflux, Chronic Rhinosinusitis (Diagnosis)
    View official trial listing →
  • Completed NCT NCT03094416

    Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors

    Not yet reported IBSA Institut Biochimique SA 66 participants Est. completion 2020-06-15 9 sites
    Other conditions: Hypothyroidism;Postablative
    View official trial listing →
  • Completed NCT NCT03100838

    Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets

    Not yet reported Food and Drug Administration (FDA) 64 participants Est. completion 2018-04-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03105375

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of X842 in Human: A Single/Multiple Ascending Dose Study

    Not yet reported Cinclus Pharma Holding AB 39 participants Est. completion 2017-10-12 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03127046

    Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers

    Not yet reported Dong Wha Pharmaceutical Co. Ltd. 30 participants Est. completion 2017-04-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03128736

    Comparing Clinical Efficacy of One-Week Dual Delayed-Release Dexlansoprazole and Esomeprazole for GERD Grade A and B

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 175 participants Est. completion 2016-03-30
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT03131973

    Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin

    Not yet reported Bristol-Myers Squibb 26 participants Est. completion 2017-11-10 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT03137134

    A Study to Evaluate the Effects of Food and Esomeprazole on the Pharmacokinetics of Crizotinib in a Coated Microsphere Formulation.

    Not yet reported Pfizer 18 participants Est. completion 2017-10-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03142620

    Effect of Vitamin D on Drug Resistant Helicobacter Pylori (HP) Eradication Study

    Not yet reported Chinese University of Hong Kong 96 participants Est. completion 2017-12 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Withdrawn NCT NCT03146325

    Helicobacter Pylori and Body Iron in Adults

    Not yet reported The University of Texas Health Science Center, Houston Est. completion 2016-08 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03163680

    Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers

    Damascus Hospital 295 participants Est. completion 2018-06-04 1 site
    Other conditions: Gastroduodenal Ulcer, Marginal Ulcer, Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT03165253

    The Effects of a Synbiotic Addition on Eradication Therapy of Helicobacter Pylori Infection in Children

    Not yet reported Bulent Ecevit University 69 participants Est. completion 2012-08
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03167398

    Fecal Microbiota Transplantation for Eradication of CRE

    Not yet reported, Not yet reported Rambam Health Care Campus 15 participants Est. completion 2019-12-30 1 site Stand-alone
    Other conditions: Antibiotic Resistant Strain, Microbial Colonization
    View official trial listing →
  • Completed NCT NCT03184324

    Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)

    Not yet reported Daewoong Pharmaceutical Co. LTD. 211 participants Est. completion 2018-04-18 1 site
    Other conditions: Erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT03195946

    Effects of Repeated Doses of Lu AF35700 on Drug Metabolizing Enzymes

    Not yet reported H. Lundbeck A/S 24 participants Est. completion 2018-01-03 1 site Stand-alone
    Other conditions: Drug Reactions
    View official trial listing →
  • Completed NCT NCT03198507

    ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active Comparator

    Not yet reported RedHill Biopharma Limited 455 participants Est. completion 2018-12-13 55 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection, Dyspepsia
    View official trial listing →
  • Completed NCT NCT03205228

    Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors

    Not yet reported Mahidol University 40 participants Est. completion 2018-07-28 1 site
    Other conditions: Globus
    View official trial listing →
  • Status unknown NCT NCT03208426

    Sequential Versus Quadruple Therapy in the Second-line Treatment

    Not yet reported National Taiwan University Hospital 240 participants Est. completion 2020-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03211143

    A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

    Not yet reported Chong Kun Dang Pharmaceutical 41 participants Est. completion 2017-08-28 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03213639

    Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)

    Not yet reported, Not yet reported Assiut University 205 participants Est. completion 2020-10-15 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT03220542

    The Effect of Broccoli Sprout Extract and Probiotics for Eradication of Helicobacter Pylori

    Not yet reported Kyunghee University Medical Center 360 participants Est. completion 2019-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03234699

    Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions

    Not yet reported SK Life Science, Inc. 24 participants Est. completion 2017-07-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03238534

    Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

    Not yet reported Aboca Spa Societa' Agricola 275 participants Est. completion 2021-09-03 12 sites Stand-alone
    Other conditions: GERD, EPS
    View official trial listing →
  • Terminated NCT NCT03267680

    IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

    Not yet reported University of Southern California 10 participants Est. completion 2024-03-13 2 sites Stand-alone
    Other conditions: Cervical Squamous Cell Carcinoma In Situ, Vulvar High Grade Squamous Intraepithelial Lesion
    View official trial listing →
  • Withdrawn NCT NCT03291249

    Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

    Not yet reported Tiziana Life Sciences LTD Est. completion 2019-06-01 Stand-alone
    MASHMASLDType 2 diabetes
    View official trial listing →
  • Completed NCT NCT03302845

    A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects

    Not yet reported Lexicon Pharmaceuticals 32 participants Est. completion 2017-11-07 1 site Stand-alone
    Other conditions: Drug-drug Interaction
    View official trial listing →
  • Status unknown NCT NCT03315676

    Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

    Not yet reported Shinshu University 124 participants Est. completion 2025-09-04 1 site
    Other conditions: Gastrointestinal Erosions and/or Ulcers
    View official trial listing →
  • Completed NCT NCT03327051

    Gastric Acid Suppression and Probiotic Colonization

    Not yet reported Stanford University 39 participants Est. completion 2018-12-30 1 site
    Other conditions: Probiotics
    View official trial listing →
  • Completed NCT NCT03333603

    Pharmacokinetics and Safety Studies of Esomeprazole Use in Schizophrenia Patients

    Not yet reported National Taiwan University Hospital 25 participants Est. completion 2017-01-23 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03333824

    Effects of AZD1775 on the PK Substrates for CYP3A, CYP2C19, CYP1A2 and on QT Interval in Patients With Advanced Cancer

    Not yet reported AstraZeneca 33 participants Est. completion 2019-01-22 7 sites Stand-alone
    Other conditions: Solid Tumours
    View official trial listing →
  • Status unknown NCT NCT03347513

    Eradication of H-pylori in Pregnancy and Its Effect on Iron Replacement Therapy?

    Not yet reported Kasr El Aini Hospital 150 participants Est. completion 2019-05 1 site Stand-alone
    Other conditions: Pregnancy Complications, Anemia, Iron Deficiency, H Pylori Infection
    View official trial listing →
  • Terminated NCT NCT03358706

    A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

    Not yet reported Janssen Research & Development, LLC 28 participants Est. completion 2021-11-22 16 sites Stand-alone
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT03362268

    IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 180 participants Est. completion 2014-07
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT03362281

    Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

    Not yet reported Livzon Pharmaceutical Group Inc. 540 participants Est. completion 2015-04
    Other conditions: Peptic Ulcer Hemorrhage
    View official trial listing →
  • Completed NCT NCT03363815

    A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

    Not yet reported Celgene 56 participants Est. completion 2018-07-29 1 site Stand-alone
    Other conditions: Heathy Volunteer
    View official trial listing →
  • Terminated NCT NCT03367195

    Efficacy and Safety of DLBS2411 in the Management of GERD

    Not yet reported Dexa Medica Group 32 participants Est. completion 2020-09-09 5 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Status unknown NCT NCT03372850

    Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations

    Not yet reported Hanmi Pharmaceutical Company Limited 96 participants Est. completion 2018-06-15 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03378960

    Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity

    Not yet reported Emilio Vargas Castrillón 43 participants Est. completion 2016-02-29 1 site
    Other conditions: Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT03383003

    Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

    Not yet reported Chang Gung Memorial Hospital 240 participants Est. completion 2018-05-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03388463

    Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.

    Not yet reported Menoufia University 110 participants Est. completion 2017-09-17
    Other conditions: Critical Illness
    View official trial listing →
  • Withdrawn NCT NCT03391674

    Fecal Microbiota Transplantation for Eradication of Carbapenem-resistant Enterobacteriaceae Colonization

    Not yet reported Rambam Health Care Campus Est. completion 2020-01-01 1 site Stand-alone
    Other conditions: Antibiotic Resistant Strain, Microbial Colonization
    View official trial listing →
  • Completed NCT NCT03405584

    High Dose of Dual Therapy Plus Bismuth for Helicobacter Pylori Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 160 participants Est. completion 2018-11-02 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03413020

    Tailored Therapy for Helicobacter Pylori Rescue Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 200 participants Est. completion 2018-07-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03428568

    Safety Trial of Herbal Melanin in Gastritis Patients

    Not yet reported King Abdullah International Medical Research Center 132 participants Est. completion 2020-03 Stand-alone
    Other conditions: Acid Dyspepsia, Gastritis
    View official trial listing →
  • Completed NCT NCT03444402

    A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects

    Not yet reported Chong Kun Dang Pharmaceutical 18 participants Est. completion 2018-05-04 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03444831

    Buspirone Plus Omeprazole for Functional Dyspepsia

    Not yet reported Isfahan University of Medical Sciences 70 participants Est. completion 2017-04-01 Stand-alone
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT03452865

    Esomeprazole to Reduce Organ Failure in Sepsis

    Not yet reported Università Vita-Salute San Raffaele 300 participants Est. completion 2023-08-21 17 sites
    Other conditions: Sepsis, Septic Shock
    View official trial listing →
  • Completed NCT NCT03457597

    Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s

    Not yet reported Corcept Therapeutics 27 participants Est. completion 2018-04-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03457727

    GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects

    Not yet reported GlaxoSmithKline 40 participants Est. completion 2018-07-25 1 site Stand-alone
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT03473665

    Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis

    Not yet reported Columbia University 9 participants Est. completion 2019-08-02 1 site
    Other conditions: Ankylosing Spondylitis, Axial Spondyloarthritis
    View official trial listing →
  • Withdrawn NCT NCT03488147

    Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery

    Not yet reported Icahn School of Medicine at Mount Sinai Est. completion 2020-07-02 2 sites
    Other conditions: Dysphagia, GERD, Degenerative Joint Disease
    View official trial listing →
  • Status unknown NCT NCT03491995

    A Unique Regimen for Treatment of Helicobacter Pylori Infection

    Not yet reported Sherief Abd-Elsalam 600 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Helicobacter Infections
    View official trial listing →
  • Completed NCT NCT03505853

    A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)

    Not yet reported Alnylam Pharmaceuticals 10 participants Est. completion 2019-01-10 1 site Stand-alone
    Other conditions: Acute Intermittent Porphyria (AIP), Acute Hepatic Porphyria (AHP), Porphyria, Acute Intermittent, Acute Porphyria
    View official trial listing →
  • Completed NCT NCT03513393

    Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.

    Not yet reported Radboud University Medical Center 11 participants Est. completion 2018-12-01 1 site Stand-alone
    Other conditions: Hepatitis C, Swallowing Disorder
    View official trial listing →
  • Status unknown NCT NCT03530228

    A Phase 1 Study of Tegoprazan on Healthy Male Volunteers

    Not yet reported HK inno.N Corporation 44 participants Est. completion 2018-08 1 site
    Other conditions: Pharmacodynamics, Pharmacokinetics, Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT03530995

    Drug-drug Interaction Between Belumosudil, Itraconazole, Rifampicin, Rabeprazole, and Omeprazole in Healthy Volunteers

    Not yet reported Kadmon Corporation, LLC 73 participants Est. completion 2019-02-08 1 site Stand-alone
    Other conditions: Drug-drug Interaction, Autoimmune Diseases, Fibrotic Disease
    View official trial listing →
  • Completed NCT NCT03531762

    Effect of a Proton Pump Inhibitor on the PK of Tepotinib

    Not yet reported Merck KGaA, Darmstadt, Germany 12 participants Est. completion 2018-07-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03547024

    A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl Estradiol

    Not yet reported Janssen-Cilag International NV 14 participants Est. completion 2018-08-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03551691

    Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI)

    Not yet reported Children's Hospital of Philadelphia 19 participants Est. completion 2022-11-02 1 site
    Other conditions: Pancreatic Insufficiency, Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT03553563

    A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

    Not yet reported AstraZeneca 50 participants Est. completion 2022-12-27 15 sites
    Other conditions: Reflux Esophagitis, Gastric Ulcer, Duodenal Ulcer
    View official trial listing →
  • Status unknown NCT NCT03555526

    Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection

    Not yet reported National Taiwan University Hospital 320 participants Est. completion 2021-12-31 1 site
    Other conditions: H Pylori Infection
    View official trial listing →
  • Completed NCT NCT03556592

    Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

    Not yet reported LEO Pharma 40 participants Est. completion 2020-06-20 12 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT03557437

    High Dose of Amoxicillin and Metronidazole Plus Bismuth For Helicobacter Pylori Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 216 participants Est. completion 2019-06-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03558477

    PK/PD Clinical Trial of YYD601 in Healthy Adult Male

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 30 participants Est. completion 2018-02-07 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03561233

    Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis

    Not yet reported Khon Kaen University 250 participants Est. completion 2018-06 Stand-alone
    Other conditions: Systemic Sclerosis, Gastroesophageal Reflux, Proton Pubm Inhibitor
    View official trial listing →
  • Completed NCT NCT03561298

    A Pharmacokinetic Study to Assess Drug-drug Interaction Between Zanubrutinib and a Cocktail of Substrates in Healthy Subjects

    Not yet reported BeiGene 18 participants Est. completion 2018-07-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03562026

    S-CEI of Nexium in Paediatric Patients

    AstraZeneca 240 participants Est. completion 2020-11-05 31 sites
    Other conditions: Peptic Ulcer, Gastroesophageal Reflux
    View official trial listing →
  • Completed NCT NCT03563287

    Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs

    Not yet reported University of Eastern Finland 13 participants Est. completion 2014-12-10 1 site Stand-alone
    Other conditions: Obesity, Morbid, Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT03592069

    Concomitant Versus Hybrid Regimen for H. Pylori Eradication

    Not yet reported Alexandra Hospital, Athens, Greece 345 participants Est. completion 2021-01-31 1 site
    Other conditions: H.Pylori Infection, H.Pylori Gastrointestinal Disease, H. Pylori Associated Phlegmonous Gastritis
    View official trial listing →
  • Completed NCT NCT03598738

    The Effect of Esomeprazole on Type 2 Diabetes

    Not yet reported Baskent University Ankara Hospital 32 participants Est. completion 2017-12-01
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03600974

    A New System for GERD Diagnosis and Treatment

    Capital Medical University 200 participants Est. completion 2021-07-01
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT03609892

    Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 658 participants Est. completion 2019-08-20 1 site
    Other conditions: Gastric Ulcer, Chronic Gastritis, Gastric Cancer, Helicobacter Pylori Infection, Gastritis
    View official trial listing →
  • Completed NCT NCT03615677

    Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 261 participants Est. completion 2019-10-18 1 site
    Other conditions: Erosive Esophagitis (EE)
    View official trial listing →
  • Status unknown NCT NCT03619408

    Management of Esophagitis Following Repair of Esophageal Atresia

    Boston Children's Hospital 50 participants Est. completion 2025-07 2 sites
    Other conditions: Esophageal Atresia, Esophagitis
    View official trial listing →
  • Completed NCT NCT03625050

    Efficacy and Safety of Chuna Manual Treatment as an Adjunctive Therapy After Total Knee Arthroplasty: A Study Protocol for a Single-Center, Randomized, Assessor Blind, Parallel-Group Clinical Trial

    Not yet reported Gachon University Gil Oriental Medical Hospital 22 participants Est. completion 2021-05-31 1 site
    Other conditions: Total Knee Replacement, Manipulation
    View official trial listing →
  • Completed NCT NCT03650543

    Effect of the CYP2C19 Polymorphism in Helicobacter Pylori Eradication

    Not yet reported Javeriana University 133 participants Est. completion 2015-08-08 Stand-alone
    Other conditions: CYP2C19 Polymorphism, H.Pylori Infection, Therapy
    View official trial listing →
  • Status unknown NCT NCT03658733

    A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

    Not yet reported Shandong University 120 participants Est. completion 2019-10-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03662269

    Indomethacin for Refractory Chronic Cough

    Not yet reported The First Affiliated Hospital of Guangzhou Medical University 84 participants Est. completion 2020-12-30 1 site Stand-alone
    Other conditions: Refractory Chronic Cough
    View official trial listing →
  • Completed NCT NCT03688828

    Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter Pylori

    Not yet reported Huazhong University of Science and Technology 360 participants Est. completion 2020-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03708211

    A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors

    Not yet reported Millennium Pharmaceuticals, Inc. 20 participants Est. completion 2019-12-03 4 sites
    Other conditions: Neoplasms, Advanced Solid
    View official trial listing →
  • Completed NCT NCT03708848

    Tailored Therapy for Helicobacter Pylori Treatment in Patients With Penicillin Allergy

    Not yet reported Shanghai Jiao Tong University School of Medicine 112 participants Est. completion 2019-09-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03709355

    Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

    Not yet reported Viriom 56 participants Est. completion 2019-09-06 1 site Stand-alone
    Other conditions: HIV-1-infection
    View official trial listing →
  • Completed NCT NCT03716427

    Drug Interaction Study of CT1812 in Healthy Volunteers

    Not yet reported Cognition Therapeutics 16 participants Est. completion 2017-02-15 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03717701

    Metformin and Esomeprazole in Treatment of Early Onset Preeclampsia

    Not yet reported Aswan University Hospital 120 participants Est. completion 2021-01-01 1 site
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Status unknown NCT NCT03717740

    Esomeprazole for the Prevention of Preeclampsia

    Not yet reported Aswan University Hospital 1000 participants Est. completion 2022-01-01 1 site
    Other conditions: Pre-Eclampsia
    View official trial listing →
  • Completed NCT NCT03718884

    A Study of Mirikizumab in Participants With Plaque Psoriasis

    Not yet reported Eli Lilly and Company 29 participants Est. completion 2019-10-28 3 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT03720366

    A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients

    Not yet reported Celgene 40 participants Est. completion 2023-12-22 10 sites Stand-alone
    Other conditions: Leukemia, Myeloid, Acute
    View official trial listing →
  • Status unknown NCT NCT03724838

    Esomeprazole With Sildenafil Citrate in Women With Early-onset Preeclampsia

    Not yet reported Aswan University Hospital 180 participants Est. completion 2022-01-01 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Status unknown NCT NCT03726099

    Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

    Not yet reported Shandong University 60 participants Est. completion 2020-12-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03730766

    Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2018-11-20 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03736369

    Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3)

    Not yet reported Daewoong Pharmaceutical Co. LTD. 263 participants Est. completion 2019-08-07 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT03757650

    THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY

    Not yet reported Fatih Sultan Mehmet Training and Research Hospital 3 participants Est. completion 2021-02-01 1 site
    Other conditions: Helicobacter Pylori Infection, Obesity, Morbid
    View official trial listing →
  • Completed NCT NCT03779087

    Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection

    Not yet reported Ping-I (William) Hsu, M.D. 112 participants Est. completion 2020-06-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT03781596

    EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone

    Not yet reported Claire Daniels 100 participants Est. completion 2022-10-02 1 site Stand-alone
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT03793556

    Evaluation of GERDOFF Efficacy in Combination With Proton Pump Inhibitor

    Not yet reported SOFAR S.p.A. 72 participants Est. completion 2018-12-11 1 site Stand-alone
    Other conditions: Gastro-oesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT03812419

    Esomeprazole or Pantoprazole in Renal Transplantation

    Not yet reported Future University in Egypt 47 participants Est. completion 2016-12-30
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03814642

    Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Male Participants

    Not yet reported HK inno.N Corporation 25 participants Est. completion 2019-07-22 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03849690

    A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

    Not yet reported Millennium Pharmaceuticals, Inc. 12 participants Est. completion 2019-04-15 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03864042

    Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

    Not yet reported Pfizer 56 participants Est. completion 2023-05-29 29 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT03866434

    Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult Participants

    Not yet reported Shire 20 participants Est. completion 2019-04-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03908619

    A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis

    Not yet reported Changi General Hospital 252 participants Est. completion 2021-03-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03928470

    Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

    Not yet reported Chong Kun Dang Pharmaceutical 379 participants Est. completion 2019-12-20 38 sites
    Other conditions: Non-erosive Reflux Disease(NERD)
    View official trial listing →
  • Completed NCT NCT03936374

    A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants

    Not yet reported Bristol-Myers Squibb 16 participants Est. completion 2019-07-20 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03943992

    Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD)

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 170 participants Est. completion 2020-07-01 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Withdrawn NCT NCT03950037

    SANCC: Clinical Trial Early Intervention

    Not yet reported Oregon Health and Science University Est. completion 2023-04 Stand-alone
    Other conditions: Subarachnoid Neurocysticercosis
    View official trial listing →
  • Status unknown NCT NCT03958344

    Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation

    Not yet reported Iran University of Medical Sciences 120 participants Est. completion 2025-06-01 1 site
    Other conditions: Orbital Pseudotumor
    View official trial listing →
  • Completed NCT NCT03967886

    Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 170 participants Est. completion 2020-05-27 1 site
    Other conditions: Non-erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT03968302

    ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

    Not yet reported Ziauddin University 196 participants Est. completion 2019-05-15 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT03979989

    Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

    Not yet reported Grünenthal GmbH 32 participants Est. completion 2005-11-16 1 site Stand-alone
    Other conditions: Pharmacokinetic
    View official trial listing →
  • Completed NCT NCT03980496

    Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding

    Not yet reported Medical University of Bialystok 50 participants Est. completion 2013-06-08 1 site
    Other conditions: Non-variceal Upper Gastrointestinal Bleeding
    View official trial listing →
  • Completed NCT NCT03980756

    A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

    Not yet reported Addpharma Inc. 88 participants Est. completion 2020-06-18 1 site
    Other conditions: Gastritis
    View official trial listing →
  • Completed NCT NCT03985319

    Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1)

    Not yet reported Yooyoung Pharmaceutical Co., Ltd. 28 participants Est. completion 2020-03-20 1 site
    Other conditions: GERD
    View official trial listing →
  • Completed NCT NCT04003350

    The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty

    Not yet reported Rothman Institute Orthopaedics 216 participants Est. completion 2019-03-15 1 site
    Other conditions: Osteo Arthritis Knee
    View official trial listing →
  • Completed NCT NCT04024527

    High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 306 participants Est. completion 2021-05-24 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT04028466

    Effectiveness of Vonoprazan vs Omeprazole as Empiric Therapy for Gastroesophageal Reflux Disease (GERD) Patients Without Alarm Features

    Not yet reported St. Luke's Medical Center, Philippines 82 participants Est. completion 2020-03-30 1 site Stand-alone
    Other conditions: GERD, Gastro Esophageal Reflux
    View official trial listing →
  • Status unknown NCT NCT04034641

    Effect of Probiotics on Helicobacter Pylori Eradication

    Not yet reported Hangzhou Grand Biologic Pharmaceutical, Inc. 238 participants Est. completion 2021-12-31 2 sites
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT04039412

    Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt

    Not yet reported Ayman Magd Eldin Mohammad Sadek 330 participants Est. completion 2019-06-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT04051853

    Sorafenib PK in Patients With Advanced HCC and Child-Pugh B

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 5 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: BCLC Stage C HCC, CP-B Liver Cirrhosis
    View official trial listing →
  • Not yet recruiting NCT NCT04069286

    EFFICACY OF ORAL AROEIRA (Schinus Terebinthifolia Raddi) COMPARED TO OMEPRAZOLE IN DYSPEPPSIA

    Not yet reported Infan Industria Quimica Farmaceutica Nacional 474 participants Est. completion 2027-03
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT04080726

    Efficacy and Safety of HIP1601 Capsule

    Not yet reported Hanmi Pharmaceutical Company Limited 213 participants Est. completion 2019-12-03 1 site
    Other conditions: Erosive Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT04090021

    Genotypic Resistance-guided Versus Empirical Therapy for H. Pylori Eradication.

    Not yet reported Konstantopoulio-Patission General Hospital of Nea Ionia 304 participants Est. completion 2020-02-28 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04108676

    Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2019-11-18 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT04128787

    A Study to Compare the Relative Bioavailability of Two AG-881 Formulations and Evaluate the Effect of Food and Omeprazole on the Pharmacokinetics of AG-881

    Not yet reported Agios Pharmaceuticals, Inc. 36 participants Est. completion 2019-12-18 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04130659

    Study to Evaluate the Performance and Safety of the MARIAL® in Association With PPI Versus PPI Alone

    Not yet reported Nekkar Lab Srl 110 participants Est. completion 2025-01-31 5 sites Stand-alone
    Other conditions: Gastroesophageal Reflux Disease (GERD)
    View official trial listing →
  • Completed NCT NCT04138836

    Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

    Not yet reported Bridge Biotherapeutics, Inc. 48 participants Est. completion 2019-11-04 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT04139226

    A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

    Not yet reported Amgen 44 participants Est. completion 2020-02-27 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04142762

    A Study to Assess CYP3A4 Modulator, Oral Contraceptive, and pH Modifier Drug Interactions for ABI-H2158 in Healthy Adults

    Not yet reported Assembly Biosciences 80 participants Est. completion 2020-01-29 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT04149470

    Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE)

    Not yet reported University of Colorado, Denver 90 participants Est. completion 2024-08 1 site Stand-alone
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT04154748

    Argon Plasma Coagulation for Barrett's Esophagus

    Not yet reported Maria Sklodowska-Curie National Research Institute of Oncology 71 participants Est. completion 2019-07-05 Stand-alone
    Other conditions: Barretts Esophagus With Low Grade Dysplasia
    View official trial listing →
  • Completed NCT NCT04156646

    A Study to Investigate the Effect of Esomeprazole and the Effect of Food on the Pharmacokinetics of Balovaptan in Healthy Volunteers

    Not yet reported Hoffmann-La Roche 16 participants Est. completion 2020-01-06 1 site
    Other conditions: Autism Spectrum Disorder
    View official trial listing →
  • Status unknown NCT NCT04170270

    Oral Omeprazole in Bleeding Peptic Ulcer

    Not yet reported Assiut University 100 participants Est. completion 2021-01 Stand-alone
    Other conditions: Bleeding Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT04178187

    The Role of Probiotics in the Eradication of Helicobacter Pylori

    Not yet reported Evangelismos Hospital 660 participants Est. completion 2021-12-31 5 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04198363

    A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection

    Not yet reported Takeda 510 participants Est. completion 2021-11-25 29 sites
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT04198948

    Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers

    Not yet reported University of Sarajevo 15 participants Est. completion 2019-08-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04199624

    Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets

    Not yet reported Indiana University 11 participants Est. completion 2023-06-07 1 site Stand-alone
    Other conditions: Hypochlorhydria
    View official trial listing →
  • Completed NCT NCT04201197

    Interactions Between Cannabinoids and Cytochrome P450-Metabolized Drugs

    Not yet reported Johns Hopkins University 22 participants Est. completion 2022-07-28 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Completed NCT NCT04233437

    Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects

    Not yet reported Moleac Pte Ltd. 27 participants Est. completion 2020-05-16 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04246762

    Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4

    Not yet reported R-Pharm International, LLC 17 participants Est. completion 2022-10-26 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04254783

    A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

    Not yet reported AbbVie 20 participants Est. completion 2022-10-14 6 sites Stand-alone
    Other conditions: Ulcerative Colitis (UC), Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT04269850

    Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

    Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 2 participants Est. completion 2024-11-27 1 site Stand-alone
    Other conditions: Intestinal GVHD
    View official trial listing →
  • Completed NCT NCT04282954

    Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

    Not yet reported Onconic Therapeutics Inc. 188 participants Est. completion 2020-12-11 1 site
    Other conditions: GERD
    View official trial listing →
  • Withdrawn NCT NCT04294823

    Sensitivity and Specificity of the Modified Helicobacter Test INFAI

    International Pharmaceutical Consultancy Est. completion 2021-02 1 site
    Other conditions: Dyspepsia, GERD
    View official trial listing →
  • Completed NCT NCT04309916

    Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance

    Not yet reported HK inno.N Corporation 46 participants Est. completion 2021-11-30 1 site
    Other conditions: Erosive Reflux Disease
    View official trial listing →
  • Completed NCT NCT04329000

    On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.

    Not yet reported Kaohsiung Veterans General Hospital. 218 participants Est. completion 2019-12-08
    Other conditions: Barrett Esophagus, Proton Pump Inhibitor, Symptom, Reflux
    View official trial listing →
  • Terminated NCT NCT04333407

    Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

    Not yet reported Imperial College London 320 participants Est. completion 2021-11-30 1 site Stand-alone
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04348786

    Comparing Efficacy of 14-day Therapy Doxycycline With Bismuth Subsalicylate Versus Levofloxacin With Tinadizole on Treatment Helicobacter Pylori

    Not yet reported Damascus Hospital 78 participants Est. completion 2020-09-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04359966

    Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia

    Not yet reported Slovenian Society for Gastroenterology and Hepatology 560 participants Est. completion 2023-09-30 3 sites
    Other conditions: Helicobacter Pylori Infection, Eradication Treatments
    View official trial listing →
  • Completed NCT NCT04368585

    Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

    Not yet reported Spero Therapeutics 20 participants Est. completion 2020-08-21 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04425902

    Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults

    Not yet reported ViiV Healthcare 20 participants Est. completion 2021-03-10 1 site Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT04432233

    Intravenous Triple Therapy in the Treatment of Helicobacter Pylori Infection and Related Complications Caused by Active Peptic Ulcer Disease

    Not yet reported Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-06-15 1 site
    Other conditions: Helicobacter Pylori Infection, Intravenous Drug Usage
    View official trial listing →
  • Completed NCT NCT04445948

    Lactoferrin in Helicobacter Pylori Eradication Either With Standard Triple Therapy or Sequential Therapy

    Not yet reported Alexandria University 400 participants Est. completion 2020-06-21 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04468815

    A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Tablets, With or Without Food, and in the Presence of an Antacid (Esomeprazole)

    Not yet reported Bristol-Myers Squibb 24 participants Est. completion 2020-10-07 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Terminated NCT NCT04504045

    Metformin's Effect on Drug Metabolism in Patients With Type 2 Diabetes

    Not yet reported University of Southern Denmark 10 participants Est. completion 2022-05-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04525235

    Phenotyping of High Dose Rifampicin

    Not yet reported Radboud University Medical Center 25 participants Est. completion 2021-08-12 2 sites Stand-alone
    Other conditions: Tuberculosis
    View official trial listing →
  • Completed NCT NCT04525664

    Assessment and Management of Chronic Dyspepsia in Eastern Uganda

    Not yet reported Washington University School of Medicine 376 participants Est. completion 2020-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Dyspepsia
    View official trial listing →
  • Enrolling by invitation NCT NCT04527055

    The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication

    Not yet reported National Cheng-Kung University Hospital 312 participants Est. completion 2028-07-31 1 site
    Other conditions: Helicobacter Pylori Infection, Dysbiosis, Probiotics
    View official trial listing →
  • Completed NCT NCT04527562

    Colchicine in Moderate Symptomatic COVID-19 Patients

    Not yet reported Dhaka Medical College 299 participants Est. completion 2020-12-10 1 site
    Other conditions: Covid19
    View official trial listing →
  • Completed NCT NCT04531059

    Rescue Therapy for Helicobacter Pylori Eradication Treatment

    Not yet reported Shanghai Jiao Tong University School of Medicine 368 participants Est. completion 2022-12-31 3 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04558502

    Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 339 participants Est. completion 2022-12-05
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT04562116

    A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

    Not yet reported Galderma R&D 17 participants Est. completion 2023-06-07 6 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT04568772

    Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

    Not yet reported Seoul National University Hospital 19 participants Est. completion 2021-08-03 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT04617613

    Comparing Different Regimens for Eradication of Helicobacter Pylori in Kuwait

    Not yet reported Al-Azhar University 603 participants Est. completion 2019-12 Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04626193

    LOAD VS Levofloxacine Concomitant

    Not yet reported Damascus Hospital 80 participants Est. completion 2024-05-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04643249

    Drug-drug Interaction Study of KL1333 in Healthy Subjects

    Not yet reported Abliva AB 14 participants Est. completion 2020-12-17 1 site Stand-alone
    Other conditions: Mitochondrial Disease
    View official trial listing →
  • Status unknown NCT NCT04652284

    Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

    Not yet reported Rabin Medical Center 300 participants Est. completion 2023-07-31
    Other conditions: Helicobacter Infections, Resistance Bacterial, Gastritis H Pylori
    View official trial listing →
  • Completed NCT NCT04660123

    A Real World Study of Bismuth Colloidal Pectin Granules Quadruple Therapy for H. Pylori Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 959 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Gastric Cancer, Helicobacter Pylori Infection, Bismuth
    View official trial listing →
  • Completed NCT NCT04672018

    Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic Gastritis

    Not yet reported University of Karachi 240 participants Est. completion 2023-02-02 1 site Stand-alone
    Other conditions: Gastritis
    View official trial listing →
  • Completed NCT NCT04676035

    The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 18 participants Est. completion 2022-01-26 1 site Stand-alone
    Other conditions: Prostate Cancer Patients
    View official trial listing →
  • Completed NCT NCT04678492

    Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 658 participants Est. completion 2021-12-20 1 site
    Other conditions: Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT04679948

    A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2021-03-17 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04696783

    The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers

    Not yet reported Fifth Affiliated Hospital, Sun Yat-Sen University 92 participants Est. completion 2021-11
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT04718181

    Bioavailability and Bioequivalence of Two Risdiplam Tablets in Healthy Participants

    Not yet reported Hoffmann-La Roche 131 participants Est. completion 2023-01-28 4 sites Stand-alone
    Other conditions: Muscular Atrophy, Spinal
    View official trial listing →
  • Completed NCT NCT04718740

    A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 33 participants Est. completion 2023-07-15 1 site Stand-alone
    Other conditions: Recurrent Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT04720781

    The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

    Not yet reported Showa Inan General Hospital 300 participants Est. completion 2024-12-31 1 site
    Other conditions: Gastroesophageal Reflux
    View official trial listing →
  • Status unknown NCT NCT04721704

    Comparison of Efficacy of Triple Regimen Based on Clarithromycin VS Metronidazole in Children

    Not yet reported Shaheed Zulfiqar Ali Bhutto Medical University 36 participants Est. completion 2022-09-14 2 sites Stand-alone
    Other conditions: H Pylori Gastritis
    View official trial listing →
  • Completed NCT NCT04753437

    A Study of Vonoprazan in Adults With Helicobacter Pylori

    Not yet reported Takeda 44 participants Est. completion 2021-11-05 1 site
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Terminated NCT NCT04764851

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates

    Not yet reported Emalex Biosciences Inc. 30 participants Est. completion 2021-05-07 1 site
    Other conditions: Drug-Interactions
    View official trial listing →
  • Terminated NCT NCT04766996

    PROUD Study - Preventing Opioid Use Disorders

    Not yet reported Emory University 57 participants Est. completion 2021-12-27 1 site
    Other conditions: Anesthesia, Opioid Use
    View official trial listing →
  • Completed NCT NCT04786938

    Effect of Probiotics on the Fecal Resistome During Helicobacter Pylori Eradication Therapy

    Not yet reported Universidad San Francisco de Quito 72 participants Est. completion 2017-06-09 Stand-alone
    Other conditions: Gut Resistome
    View official trial listing →
  • Status unknown NCT NCT04803162

    The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE

    Wroclaw Medical University 58 participants Est. completion 2021-12 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT04810793

    The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

    Shandong University 820 participants Est. completion 2022-06-30 1 site
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT04834752

    Effect of H2 Receptor Antagonist and Proton Pump Inhibitor on the Positivity Rates and Clinical Outcomes of COVID-19

    Seoul National University Hospital 400000 participants Est. completion 2021-12-31 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04840641

    Flucloxacillin as an Inducer of CYP-enzymes

    Not yet reported University of Southern Denmark 14 participants Est. completion 2021-12-28 1 site
    Other conditions: Healthy Volunteers, Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT04840888

    A Study of LY3484356 in Healthy Female Participants

    Not yet reported Eli Lilly and Company 82 participants Est. completion 2022-04-12 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04865731

    Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio 6 participants Est. completion 2024-06-18 1 site
    Other conditions: Cancer of the Head and Neck
    View official trial listing →
  • Completed NCT NCT04876807

    A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered With Omeprazole

    Not yet reported Acerta Pharma BV 36 participants Est. completion 2016-03-15 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04879992

    Rifabutin-containing Triple Therapy for Treatment of Helicobacter Pylori

    Not yet reported Shanghai Jiao Tong University School of Medicine 413 participants Est. completion 2022-10-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04901663

    Vonoprazan in Helicobacter Pylori Treatment an RCT

    Not yet reported Dow University of Health Sciences 179 participants Est. completion 2021-08-16 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT04907747

    Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 234 participants Est. completion 2022-04-13 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT04914936

    A Study to Evaluate the One-way Interaction of Calcium Carbonate, Omeprazole, or Rifampin on ACP-196

    Not yet reported Acerta Pharma BV 72 participants Est. completion 2014-10-16 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Terminated NCT NCT04930991

    High Dose Omeprazole in Patients With Pancreatic Cancer

    Not yet reported University of Oklahoma 25 participants Est. completion 2026-04-03 1 site Stand-alone
    Other conditions: Exocrine Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT04942652

    Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers

    Not yet reported Seoul National University Hospital 13 participants Est. completion 2021-08-24 1 site
    Other conditions: Achlorhydria
    View official trial listing →
  • Terminated NCT NCT04959266

    A Study to Assess the Effects of Itraconazole, Rifampicin, and Omeprazole on Pharmacokinetics of Adavosertib

    Not yet reported AstraZeneca 5 participants Est. completion 2022-06-01 5 sites Stand-alone
    Other conditions: Advanced Solid Tumours
    View official trial listing →
  • Completed NCT NCT04989829

    Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2022-02-14 1 site Stand-alone
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Terminated NCT NCT04990804

    Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery

    Not yet reported Vanderbilt University Medical Center 8 participants Est. completion 2022-02-01 1 site Stand-alone
    Other conditions: Opioid Use, Spinal Diseases, Surgery--Complications, Surgery, Postoperative Pain
    View official trial listing →
  • Status unknown NCT NCT04991584

    Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection

    Not yet reported Shandong University 60 participants Est. completion 2022-07-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05038969

    Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)

    Not yet reported Genuine Research Center, Egypt 30 participants Est. completion 2021-05-28 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05041920

    A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2021-10-27 1 site Stand-alone
    Other conditions: Tumor
    View official trial listing →
  • Completed NCT NCT05051566

    A Multiple Dose Study of LY3502970 in Healthy Participants

    Not yet reported Eli Lilly and Company 26 participants Est. completion 2022-04-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05061303

    Omeprazole and Famotidine in Chronic Dysfunction of the Transplanted Kidney

    Poznan University of Medical Sciences 24 participants Est. completion 2024-06-30 1 site
    Other conditions: Kidney Rejection Transplant
    View official trial listing →
  • Completed NCT NCT05061563

    A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

    Not yet reported Bayer 14 participants Est. completion 2022-02-23 1 site
    Other conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes
    View official trial listing →
  • Completed NCT NCT05067439

    A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

    Not yet reported Pfizer 26 participants Est. completion 2022-02-26 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05070351

    Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy

    Not yet reported, Not yet reported Duke University 33 participants Est. completion 2025-06-02 1 site Stand-alone
    Other conditions: Hepatic Encephalopathy
    View official trial listing →
  • Status unknown NCT NCT05100446

    Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

    Not yet reported Unidade Local de Saúde do Alto Ave, EPE 100 participants Est. completion 2022-12-31 1 site
    Other conditions: Helicobacter Pylori Infection, Gastritis, Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT05107999

    Stigma and Efficacy of Zhizhu Kuanzhong Capsules

    Not yet reported RenJi Hospital 76 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Functional Gastrointestinal Disorders, Dyspepsia, Psychosomatic Disorder
    View official trial listing →
  • Completed NCT NCT05109390

    A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 72 participants Est. completion 2018-10-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05123820

    Pharmacokinetics of Omeprazole and Midazolam When Co-administered With ACT-1014-6470

    Not yet reported Idorsia Pharmaceuticals Ltd. 20 participants Est. completion 2021-11-24 1 site Stand-alone
    Other conditions: Drug Drug Interaction, Healthy
    View official trial listing →
  • Completed NCT NCT05134350

    Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants

    Not yet reported Loxo Oncology, Inc. 10 participants Est. completion 2020-03-23 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05134584

    Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders

    Not yet reported RenJi Hospital 78 participants Est. completion 2022-02 1 site Stand-alone
    Other conditions: Functional Dyspepsia, Constipation-predominant Irritable Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT05173493

    The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

    Shandong University 670 participants Est. completion 2023-02-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05176821

    Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection

    Not yet reported Shanghai Zhongshan Hospital 186 participants Est. completion 2022-12-31 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05189444

    The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori

    Not yet reported Huazhong University of Science and Technology 672 participants Est. completion 2022-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05232994

    Metformin and Esomeprazole For Preterm Pre-eclampsia

    Not yet reported Christiana Care Health Services 38 participants Est. completion 2025-12-31 1 site
    Other conditions: Preeclampsia Severe, Preeclampsia Second Trimester, Preterm Birth Complication
    View official trial listing →
  • Completed NCT NCT05237115

    Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Xijing Hospital of Digestive Diseases 600 participants Est. completion 2020-12-05 1 site
    Other conditions: Gastritis, Peptic Ulcer, Dyspepsia
    View official trial listing →
  • Withdrawn NCT NCT05250050

    Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment

    Not yet reported Shanghai Zhongshan Hospital Est. completion 2023-03-01 3 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05254548

    A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

    Not yet reported Idorsia Pharmaceuticals Ltd. 22 participants Est. completion 2022-04-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05256342

    Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

    Not yet reported Rambam Health Care Campus 17 participants Est. completion 2024-04-08 2 sites
    Osteoarthritis Other conditions: Biomarkers for Prediction of OA Treatment Efficacy
    View official trial listing →
  • Status unknown NCT NCT05264142

    Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status

    Not yet reported University Hospital, Geneva 45 participants Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05265247

    Bioequivalence Study of Esomeprazole 20 Milligram (mg) Delayed-Release Capsules in Healthy Adult Participants

    Not yet reported HALEON 61 participants Est. completion 2022-06-02 1 site
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT05267613

    Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

    Not yet reported AstraZeneca 53 participants Est. completion 2026-08-19 41 sites
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT05273775

    A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 22 participants Est. completion 2022-06-23 1 site Stand-alone
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT05287633

    Proton Pump Inhibitors Effects on Dyspepsia During Ramadan Fasting

    Not yet reported, Not yet reported University of Monastir 500 participants Est. completion 2024-12-30 1 site
    Other conditions: Dyspepsia
    View official trial listing →
  • Completed NCT NCT05319899

    A Study of ALXN1840 (Non-coated) Administered With And Without Omeprazole In Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 18 participants Est. completion 2014-03-24 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05319912

    A Study of ALXN1840 (Coated and Non-coated) Administered With And Without Omeprazole In Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 18 participants Est. completion 2014-05-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05334108

    Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

    Not yet reported Emalex Biosciences Inc. 56 participants Est. completion 2022-08-26 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Completed NCT NCT05338502

    Study of H2 Antagonist and a Proton Pump Inhibitor of Selpercatinib in Healthy Participants

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2019-09-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05342532

    High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population

    Not yet reported Icahn School of Medicine at Mount Sinai 112 participants Est. completion 2022-01-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05368831

    Open-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy Subjects

    Not yet reported NorthSea Therapeutics B.V. 24 participants Est. completion 2022-09-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05392127

    A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunteers

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 24 participants Est. completion 2022-08-18 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Enrolling by invitation NCT NCT05395949

    A Randomized Controlled Study of Conservative Treatment of Granulomatous Lobular Mastitis Combined With Psychiatric Disorders

    Not yet reported Wuhan University 50 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Breast Diseases, Mastitis Granulomatous, Psychiatric Disorder
    View official trial listing →
  • Completed NCT NCT05431075

    Bismuth-containing Quadruple Therapy for Helicobacter Pylori First-line Treatment of Different Tetracycline Doses

    Not yet reported Shandong University 406 participants Est. completion 2024-02-01 6 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05432115

    Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

    Not yet reported Shandong University 407 participants Est. completion 2023-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05433896

    Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions

    Not yet reported Xspray Pharma AB 17 participants Est. completion 2020-12-19 1 site
    Other conditions: Pharmacokinetics, Drug Interactions
    View official trial listing →
  • Completed NCT NCT05438303

    Study to Assess the Effect of Co-Administration of AZD9833 on the Pharmacokinetics of Midazolam, of Omeprazole, of Celecoxib and of Dabigatran Etexilate in Healthy Postmenopausal Female Volunteers

    Not yet reported AstraZeneca 59 participants Est. completion 2022-12-13 2 sites Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05438550

    14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection

    Not yet reported Shandong University 258 participants Est. completion 2023-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05443984

    JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

    Not yet reported Onconic Therapeutics Inc. 300 participants Est. completion 2023-01-05 1 site
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Completed NCT NCT05444556

    A Study of Imlunestrant (LY3484356) in Female Healthy Participants

    Not yet reported Eli Lilly and Company 113 participants Est. completion 2022-11-02 3 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05467475

    A Study in Healthy Men to Test How Esomeprazole Influences the Amount of BI 1819479 in the Blood

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2023-01-23 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05468164

    A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants

    Not yet reported Eli Lilly and Company 20 participants Est. completion 2018-09-13 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05474924

    The Role of Budesonide Intrapolyp Injection in CRSwNP

    Not yet reported Kafrelsheikh University 90 participants Est. completion 2022-12-01 1 site
    Other conditions: CRS, Polyp, Nasal
    View official trial listing →
  • Status unknown NCT NCT05480241

    Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy

    Not yet reported Unidade Local de Saúde de Coimbra, EPE 84 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Acute Pancreatitis, Exocrine Pancreatic Insufficiency, Gut Microbiota, Immunology
    View official trial listing →
  • Completed NCT NCT05487235

    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

    Not yet reported Genentech, Inc. 57 participants Est. completion 2025-06-23 25 sites Stand-alone
    Other conditions: Advanced Solid Tumors, Metastatic Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT05493644

    A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

    Shandong University 660 participants Est. completion 2023-12-31
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05497557

    A Study to Evaluate the Impact of Omeprazole on the Pharmacokinetics of Sotorasib Co-administered With an Acidic Beverage in Healthy Volunteers

    Not yet reported Amgen 16 participants Est. completion 2022-09-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05563350

    Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms

    University Hospital Bispebjerg and Frederiksberg 26 participants Est. completion 2023-07-01 1 site
    Other conditions: Alcohol Withdrawal
    View official trial listing →
  • Completed NCT NCT05566405

    The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic Prostatectomy

    Not yet reported Sismanoglio General Hospital 60 participants Est. completion 2022-09-30 1 site
    Other conditions: Prostatic Neoplasm
    View official trial listing →
  • Completed NCT NCT05577468

    Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 561 participants Est. completion 2023-09-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05581992

    Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

    Not yet reported Amgen 14 participants Est. completion 2020-01-26 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Status unknown NCT NCT05586464

    Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine

    Not yet reported Liaocheng People's Hospital 600 participants Est. completion 2024-09-30
    Other conditions: Helicobacter Pylori Infection, Traditional Chinese Medicine, Eradication
    View official trial listing →
  • Status unknown NCT NCT05586568

    Drug-drug Interaction Study of XZP-3621 Tablet

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 72 participants Est. completion 2023-08-02 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT05590286

    A RCT of the Efficacy of Vonoprazan 20mg QD in the Treatment of Helicobacter Pylori Infection

    Not yet reported First People's Hospital of Hangzhou 100 participants Est. completion 2024-12-31 1 site
    Other conditions: Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor
    View official trial listing →
  • Completed NCT NCT05599828

    A Study to Evaluate the Impact of Acid-reducing Agents on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

    Not yet reported Amgen 14 participants Est. completion 2020-09-13 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT05609929

    Study the Effect of Omeprazole on AB-106 Pharmacokinetics

    Not yet reported Nuvation Bio Inc. 24 participants Est. completion 2023-01-20 1 site Stand-alone
    Other conditions: Pharmacokinetic Study
    View official trial listing →
  • Status unknown NCT NCT05620589

    The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

    Shandong University 626 participants Est. completion 2024-12-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT05624229

    Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding

    Not yet reported West China Hospital 672 participants Est. completion 2028-12-31
    Other conditions: Upper Gastrointestinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT05635110

    Evaluation of the Effects of Omeprazole and Rifampin on the Pharmacokinetics of VX-548 in Healthy Participants

    Not yet reported Vertex Pharmaceuticals Incorporated 31 participants Est. completion 2023-06-08 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT05647278

    Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)

    Not yet reported Zhang Xiaofeng,MD 370 participants Est. completion 2025-10-31 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT05651074

    Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

    Not yet reported Jiangsu vcare pharmaceutical technology co., LTD 20 participants Est. completion 2023-04 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05657613

    Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects

    Not yet reported CTI BioPharma 60 participants Est. completion 2023-06-08 1 site Stand-alone
    Other conditions: Drug Interactions
    View official trial listing →
  • Completed NCT NCT05664685

    Optimized Bismuth Quadruple Therapy vs Triple Standard Therapy for Helicobacter Pylori Eradication

    Not yet reported Pontificia Universidad Catolica de Chile 127 participants Est. completion 2024-01-30 2 sites Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Terminated NCT NCT05671653

    A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

    Not yet reported Pfizer 32 participants Est. completion 2023-11-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT05680870

    The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients

    Not yet reported Aya Mohamed Sadek Elsaid 46 participants Est. completion 2024-12-12 1 site Stand-alone
    Other conditions: Chemotherapy Induced Peripheral Neuropathy
    View official trial listing →
  • Completed NCT NCT05688124

    A Study of IBI351 in Healthy Subjects

    Not yet reported Innovent Biologics (Suzhou) Co. Ltd. 24 participants Est. completion 2023-10-16 1 site
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT05701540

    A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn

    Not yet reported HK inno.N Corporation 338 participants Est. completion 2024-12-31 1 site
    Other conditions: Gastroesophageal Reflux Disease
    View official trial listing →
  • Status unknown NCT NCT05726734

    Vonoprazan-containing Triple Therapy Versus Empiric Bismuth Quadruple Therapy for First-line Helicobacter Pylori Treatment: a Randomized Clinical Trial

    Not yet reported Shanghai East Hospital 100 participants Est. completion 2026-02-06 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05741385

    A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

    Not yet reported Boehringer Ingelheim 4 participants Est. completion 2024-08-23 1 site Stand-alone
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT05742568

    Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

    Not yet reported Xijing Hospital of Digestive Diseases 124 participants Est. completion 2024-03-10 1 site
    Other conditions: Gastritis, Dyspepsia, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer
    View official trial listing →
  • Terminated NCT NCT05753774

    Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

    Not yet reported Biao Zou 47 participants Est. completion 2026-03-09 1 site
    Other conditions: Functional Gastrointestinal Disorders
    View official trial listing →
  • Status unknown NCT NCT05802888

    Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.

    Not yet reported Shandong University 260 participants Est. completion 2024-06-15 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Active, not recruiting NCT NCT05822544

    Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

    Not yet reported OrsoBio, Inc 564 participants Est. completion 2027-01 4 sites Stand-alone
    Type 2 diabetes Other conditions: Healthy Subjects, Obesity
    View official trial listing →
  • Completed NCT NCT05826574

    A Study to Assess Pharmacokinetics (PK) of Brensocatib Alone and With Multiple Doses of Rifampin or Esomeprozole in Healthy Participants

    Not yet reported Insmed Incorporated 32 participants Est. completion 2023-07-16 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05841394

    A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding

    Not yet reported Livzon Pharmaceutical Group Inc. 449 participants Est. completion 2022-04-28 2 sites
    Other conditions: Stress Ulcer Bleeding
    View official trial listing →
  • Completed NCT NCT05845645

    A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B

    Not yet reported UCB Biopharma SRL 73 participants Est. completion 2024-04-13 1 site
    Other conditions: Healthy Study Participants
    View official trial listing →
  • Completed NCT NCT05849883

    Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

    Not yet reported PT Kalbe Farma Tbk 36 participants Est. completion 2021-02-03 1 site Stand-alone
    Other conditions: Drug Use
    View official trial listing →
  • Status unknown NCT NCT05850117

    Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p

    Not yet reported Kaohsiung Medical University 240 participants Est. completion 2024-12-31 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT05852769

    A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants

    Not yet reported Bristol-Myers Squibb 18 participants Est. completion 2023-08-24 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05861687

    Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children

    Not yet reported, Not yet reported Finni Kollins 51 participants Est. completion 2022-05-20 2 sites
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05863858

    Eradication of H. Pylori Infection With Moxifloxacin

    Not yet reported Iyad Naeem Muhammad, PhD 162 participants Est. completion 2022-06-08 1 site
    Other conditions: Helicobacter Pylori Infection, Helicobacter Pylori Infection, Susceptibility to
    View official trial listing →
  • Status unknown NCT NCT05870683

    Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)

    Not yet reported Yanqing Li 368 participants Est. completion 2023-12-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT05891119

    Study to Investigate the Effect of Rocatinlimab (AMG 451) on the Pharmacokinetics of Multiple Cytochrome P450 (CYP450) Substrates in Participants With Moderate to Severe Atopic Dermatitis

    Not yet reported Amgen 21 participants Est. completion 2025-02-12 7 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT05893849

    Pharmacokinetics of Clinical Probes and Characteristics of Endogenous Biomarker in Chinese Older Adults

    Peking University Third Hospital 624 participants Est. completion 2024-04 1 site
    Other conditions: Aging
    View official trial listing →
  • Status unknown NCT NCT05925140

    LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients

    Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sites Stand-alone
    Other conditions: COVID-19, Hospitalized COVID-19 Patients
    View official trial listing →
  • Completed NCT NCT05932277

    A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Participants

    Not yet reported Bristol-Myers Squibb 22 participants Est. completion 2023-09-13 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05981365

    Voxelotor CYP and Transporter Cocktail Interaction Study

    Not yet reported Pfizer 44 participants Est. completion 2023-10-04 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT06031454

    Drug-durg Interaction of Leritrelvir(RAY1216) With Midazolam, Omeprazole, Rosuvastatin, Verapamil, and Rifampin

    Not yet reported Guangdong Raynovent Biotech Co., Ltd 56 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT06050824

    A Comparative Study Between Concomitant Versus Load Therapy in Eradication of Helicobacter Pylori Infection

    Not yet reported Helwan University 200 participants Est. completion 2023-07-19 1 site
    Other conditions: H. Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT06065267

    Levofloxacin Concomitant Versus Levofloxacin Sequential

    Not yet reported Damascus Hospital 150 participants Est. completion 2027-06-30 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06093945

    Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2023-11-29 1 site Stand-alone
    Other conditions: Malignant Tumor
    View official trial listing →
  • Completed NCT NCT06101420

    Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication

    Not yet reported Ain Shams University 232 participants Est. completion 2023-06-01 1 site
    Other conditions: Helicobacter Pylori Eradication
    View official trial listing →
  • Completed NCT NCT06105255

    A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553

    Not yet reported InventisBio Co., Ltd 45 participants Est. completion 2024-02-02 1 site Stand-alone
    Other conditions: Healthy Male
    View official trial listing →
  • Status unknown NCT NCT06121245

    The PRO-SOma COla (PROSOCO) Study

    Not yet reported University of Copenhagen 11 participants Est. completion 2024-02 2 sites
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06145217

    An Drug-drug Interaction Study to Evaluate the Effects of Omeprazole 40mg on the Pharmacokinetics of SPRYCEL®

    Not yet reported Xspray Pharma AB 18 participants Est. completion 2023-08-29 1 site Stand-alone
    Other conditions: Drug-drug Interaction Study
    View official trial listing →
  • Status unknown NCT NCT06159218

    Eosinophilic Oesophagitis Assessment With String Testing

    Not yet reported St George's, University of London 50 participants Est. completion 2023-12-31 1 site
    Other conditions: Eosinophilic Esophagitis
    View official trial listing →
  • Completed NCT NCT06162169

    A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects

    Not yet reported Allist Pharmaceuticals, Inc. 66 participants Est. completion 2024-02-20 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06162949

    Vonoprazan for Helicobacter Pylori Eradication in Adolescents

    Not yet reported Alexandria University 242 participants Est. completion 2024-08-01 1 site
    Other conditions: Treatment Effectiveness
    View official trial listing →
  • Status unknown NCT NCT06164834

    Effect of Tegoprazan on Pharmacodynamics of Clopidogrel in Healthy Subjects

    Not yet reported HK inno.N Corporation 48 participants Est. completion 2024-11 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06168084

    Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

    Not yet reported Yongquan Shi 688 participants Est. completion 2024-08-30 2 sites
    Other conditions: Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer
    View official trial listing →
  • Completed NCT NCT06181084

    A Study Comparing Different Formulations of LY3410738 in Healthy Adult Participants

    Not yet reported Eli Lilly and Company 60 participants Est. completion 2022-04-28 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06193811

    A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2024-03-14 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06213818

    A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

    Not yet reported Incyte Corporation 137 participants Est. completion 2025-08-19 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06215430

    A Study of Effect of Multiple Doses of LOXO-305 on the Pharmacokinetics of Single Oral Doses of CYP1A2, CYP2C9, CYP2C19 Substrates in Healthy Participants

    Not yet reported Eli Lilly and Company 16 participants Est. completion 2021-04-15 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06216639

    Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection

    National Institute of Public Health, Slovenia 2000 participants Est. completion 2025-01 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT06233097

    Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fasting Condition

    Not yet reported Bio-innova Co., Ltd 30 participants Est. completion 2024-10-12
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06233149

    Esomeprazole Magnesium Dihydrate 40 mg Tablets Relative to Nexium 40 mg Tablets Under Fed Condition

    Not yet reported Bio-innova Co., Ltd 40 participants Est. completion 2024-12-03
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06250634

    Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection

    Not yet reported The Third Xiangya Hospital of Central South University 806 participants Est. completion 2024-05-10 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06268834

    Is Long-Term Proton Pump Inhibitor Use a Cause of Leaky Gut Syndrome

    Not yet reported Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital 75 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Proton Pump Inhibitor Adverse Reaction
    View official trial listing →
  • Completed NCT NCT06275841

    A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant

    Not yet reported Pfizer 12 participants Est. completion 2024-05-24 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06279234

    A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

    Not yet reported Pfizer 50 participants Est. completion 2025-04-11 2 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06283381

    The ESG Integrity Study: Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40 participants Est. completion 2026-06-30 1 site
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT06302049

    Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis

    Not yet reported, Not yet reported Sadat City University 46 participants Est. completion 2026-05-01 1 site
    Other conditions: Fatty Liver Disease, Steatohepatitis, Nonalcoholic
    View official trial listing →
  • Completed NCT NCT06315478

    Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians

    Not yet reported Helwan University 60 participants Est. completion 2021-11-01 1 site
    Other conditions: H.Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT06318104

    Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole

    Not yet reported Hospital General de México Dr. Eduardo Liceaga 160 participants Est. completion 2025-02-28
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Completed NCT NCT06322706

    A Clinical Trial to Evaluate a High-Fat Meal and Omeprazole Enteric-coated Tablets on ASBK021

    Not yet reported Abbisko Therapeutics Co, Ltd 36 participants Est. completion 2024-11-01 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Terminated NCT NCT06359015

    Metformin and Esomeprazole in Preterm Pre-eclampsia

    Not yet reported Christiana Care Health Services 4 participants Est. completion 2025-05-08 1 site
    Other conditions: Preeclampsia Severe, Pre-Eclampsia, Preeclampsia, Preeclampsia Second Trimester, Preeclampsia Complicating Childbirth, Preeclampsia Puerperium, Preterm
    View official trial listing →
  • Completed NCT NCT06366243

    A Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Emraclidine in Healthy Adult Participants

    Not yet reported Cerevel Therapeutics, LLC 20 participants Est. completion 2024-06-20 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06378398

    A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy

    Not yet reported University of Michigan Rogel Cancer Center 21 participants Est. completion 2026-02-17 2 sites Stand-alone
    Other conditions: Colorectal Neoplasia
    View official trial listing →
  • Completed NCT NCT06378658

    A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants

    Not yet reported Bayer 21 participants Est. completion 2024-06-11 1 site
    Other conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06419660

    A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood

    Not yet reported Boehringer Ingelheim 15 participants Est. completion 2024-07-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06494761

    A Study in Healthy Men to Test Whether Zongertinib Affects How 3 Other Medicines (Midazolam, Omeprazole, and Repaglinide) Are Taken up and Processed by the Body

    Not yet reported Boehringer Ingelheim 16 participants Est. completion 2024-10-16 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT06502288

    Evaluation of Antibiotic Administration Following Tooth Extraction

    Not yet reported Chittagong Medical College 152 participants Est. completion 2025-10-15 1 site Stand-alone
    Other conditions: Tooth Extraction
    View official trial listing →
  • Enrolling by invitation NCT NCT06509139

    Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males

    Not yet reported National Cheng-Kung University Hospital 661 participants Est. completion 2032-07-31 1 site
    Other conditions: Helicobacter Pylori Infection, Sex, Bismuth Quadruple Therapy
    View official trial listing →
  • Completed NCT NCT06514274

    Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

    Not yet reported Xijing Hospital of Digestive Diseases 558 participants Est. completion 2025-06-25 1 site
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Active, not recruiting NCT NCT06523764

    Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment

    Not yet reported Xijing Hospital of Digestive Diseases 208 participants Est. completion 2025-10-01 1 site
    Other conditions: Helicobacter Pylori Infection Chronic Gastrit
    View official trial listing →
  • Not yet recruiting NCT NCT06526455

    Efficacy and Safety of Vonorasan Versus Esomeprazole in the Treatment of Ulcers After Endoscopic Submucosal Dissection

    Not yet reported Shicai Ye 196 participants Est. completion 2029-06-30 4 sites
    Other conditions: Ulcers, Gastric
    View official trial listing →
  • Status unknown NCT NCT06539494

    Luminal Fructose Kinetics (MARTINI Study)

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 22 participants Est. completion 2026-04 1 site
    MASLD
    View official trial listing →
  • Status unknown NCT NCT06546111

    Clinical Study to Evaluate the Possible Efficacy and Safety of Diosmin and Hesperidin Combined Therapy in Patients With Helicobacter Pylori Infection

    Not yet reported, Not yet reported Sadat City University 46 participants Est. completion 2026-10-01 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Status unknown NCT NCT06561542

    A Phase I Study of LX22001 for Injection in Healthy Subjects

    Not yet reported Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. 70 participants Est. completion 2025-11-21 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06566794

    KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

    Not yet reported Helsinki University Central Hospital 12 participants Est. completion 2025-01-10 1 site
    Other conditions: Drug Interaction
    View official trial listing →
  • Status unknown NCT NCT06603688

    Study on the Efficacy and Safety of Berberine, Minocycline, Esomeprazole, and Colloidal Bismuth Quadruple Therapy in the Initial Treatment of Helicobacter Pylori.

    Not yet reported Xijing Hospital of Digestive Diseases 548 participants Est. completion 2024-12-01 1 site
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis
    View official trial listing →
  • Completed NCT NCT06605950

    A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Xanomeline With Trospium Chloride Versus KarXT in Healthy Adult and Elderly Participants of Japanese Ethnicity and to Assess the Effect of Omeprazole on the PK of Xanomeline With Trospium Chloride in Healthy Adult Participants

    Not yet reported Karuna Therapeutics, Inc., a Bristol Myers Squibb company 78 participants Est. completion 2025-05-31 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06686628

    An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

    Not yet reported Sanofi 23 participants Est. completion 2026-04-02 1 site Stand-alone
    Other conditions: Dermatitis Atopic
    View official trial listing →
  • Completed NCT NCT06717269

    A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

    Not yet reported Nurix Therapeutics, Inc. 223 participants Est. completion 2026-05-01 2 sites
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Enrolling by invitation NCT NCT06719622

    Evaluation of the Efficacy of Local Budesonide Treatment in Children with Crohn's Disease Located in the Esophagus And/or Stomach And/or Duodenum

    Not yet reported, Not yet reported Medical University of Warsaw 114 participants Est. completion 2027-12-31 3 sites
    Other conditions: Crohn Disease (CD)
    View official trial listing →
  • Not yet recruiting NCT NCT06720610

    Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis

    Not yet reported Universitas Indonesia 216 participants Est. completion 2025-06-27 5 sites
    Other conditions: Erosive Esophagitis
    View official trial listing →
  • Not yet recruiting NCT NCT06783257

    Phase II Clinical Study of Vonorasan Fumarate Injection in the Treatment of Peptic Ulcer Bleeding

    Not yet reported Shandong New Time Pharmaceutical Co., LTD 150 participants Est. completion 2027-02
    Other conditions: Peptic Ulcer Bleeding
    View official trial listing →
  • Completed NCT NCT06793943

    A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

    Not yet reported Takeda 78 participants Est. completion 2025-03-30 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06810492

    The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

    Not yet reported Hongmei Zheng, PhD 40 participants Est. completion 2027-12-01
    Other conditions: Breast Cancer Stage III, Breast Cancer Stage II
    View official trial listing →
  • Status unknown NCT NCT06811207

    Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication

    Not yet reported Chang Gung Memorial Hospital 300 participants Est. completion 2025-02-28 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS
    View official trial listing →
  • Completed NCT NCT06822166

    Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride

    Not yet reported Ahon Pharmaceutical Co., Ltd. 68 participants Est. completion 2024-01-23 1 site Stand-alone
    Other conditions: Interaction Drug Food
    View official trial listing →
  • Completed NCT NCT06823791

    Furazolidone Quadruple Regimen Eradicate H. Pylori Infection

    Not yet reported, Not yet reported Liaocheng People's Hospital 493 participants Est. completion 2024-07-30 1 site
    Other conditions: Helicobacter Pylori Infection, Eradication
    View official trial listing →
  • Completed NCT NCT06851468

    Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

    Not yet reported Key Laboratory for Gastrointestinal Diseases of Gansu Province 264 participants Est. completion 2025-11-30 1 site
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Not yet recruiting NCT NCT06903585

    Non Steroidal Anti-inflammatory Drugs in the Prevention of Bone Pain Flares After Palliative Radiotherapy

    Not yet reported American University of Beirut Medical Center 385 participants Est. completion 2029-04 1 site
    Other conditions: Bone Pain Flare, Bone Metastasis
    View official trial listing →
  • Completed NCT NCT06930872

    Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates

    Not yet reported Harmony Biosciences Management, Inc. 29 participants Est. completion 2025-11-04 1 site Stand-alone
    Other conditions: Drug Interaction
    View official trial listing →
  • Not yet recruiting NCT NCT06943482

    Comparing Effectiveness of Steroids and Methotrexate in Treatment of Chronic Inflammatory Breast Disease

    Not yet reported National University Hospital, Singapore 40 participants Est. completion 2028-02-01 1 site
    Other conditions: Idiopathic Granulomatous Mastitis
    View official trial listing →
  • Not yet recruiting NCT NCT06943794

    Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial

    Not yet reported Fudan University 4824 participants Est. completion 2030-12-30 1 site Stand-alone
    Other conditions: Gastric (Stomach) Cancer
    View official trial listing →
  • Completed NCT NCT06948006

    A Study to Investigate the Relative Bioavailability of 2 Different Formulations of AZD4144, the Effect of Food and Omeprazole on the Pharmacokinetics of AZD4144 in Healthy Participants

    Not yet reported AstraZeneca 32 participants Est. completion 2025-06-27 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT06949124

    A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 20 participants Est. completion 2025-06-05 1 site
    Other conditions: Endometriosis, Uterine Fibroids, Assisted Reproduction
    View official trial listing →
  • Not yet recruiting NCT NCT06966856

    This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcting Early-onset Vitamin B12 Deficiency in Adult Patients Using Proton Pump Inhibitors (PPIs). The Primary Outcome is the Change in Serum Vitamin B12 Levels Over a 6-week

    Not yet reported Tanta University 23 participants Est. completion 2029-12-30
    Other conditions: Hypovitaminosis b 12
    View official trial listing →
  • Completed NCT NCT06973889

    Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients

    Not yet reported Mashhad University of Medical Sciences 60 participants Est. completion 2025-01-21 2 sites Stand-alone
    Other conditions: HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease
    View official trial listing →
  • Completed NCT NCT06975605

    Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs.

    Not yet reported GRIN Therapeutics, Inc. 18 participants Est. completion 2025-07-10 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex (TSC), Focal Cortical Dysplasia, Other Neurological Disorders
    View official trial listing →
  • Completed NCT NCT07007806

    Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

    Not yet reported Atea Pharmaceuticals, Inc. 20 participants Est. completion 2025-06-28 1 site Stand-alone
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Enrolling by invitation NCT NCT07016737

    Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy

    Not yet reported Ye jinjun 79 participants Est. completion 2029-09-01 1 site
    Other conditions: Esophageal Squamous Cell Carcinoma (ESCC)
    View official trial listing →
  • Completed NCT NCT07018635

    A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

    Not yet reported Incyte Corporation 63 participants Est. completion 2025-09-29 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07021729

    Comparison of Two Treatment Regimens of Helicobacter Pylori Infection

    Not yet reported Rehman Medical Institute - RMI 156 participants Est. completion 2026-06
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07040839

    Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection

    Not yet reported Rehman Medical Institute - RMI 128 participants Est. completion 2026-02 1 site Stand-alone
    Other conditions: H Pylori
    View official trial listing →
  • Completed NCT NCT07068841

    Pharmacokinetic Effect of Y-3 on Repaglinide,Warfarin and Omeprazole in Healthy Participants

    Not yet reported Neurodawn Pharmaceutical Co., Ltd. 24 participants Est. completion 2025-06-29 1 site Stand-alone
    Other conditions: Pharmacokinetic Profiles, Y-3 for Injection, Drug-drug Interaction, Repaglinide Tablets, Warfarin Sodium Tablets, Omeprazole Enteric-coated Capsules, Safty
    View official trial listing →
  • Completed NCT NCT07086937

    Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children

    Not yet reported Muhammad Aamir Latif 66 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07104318

    Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans

    Not yet reported VA Office of Research and Development 360 participants Est. completion 2030-03-31 1 site Stand-alone
    Other conditions: Helicobacter Pylori
    View official trial listing →
  • Completed NCT NCT07138235

    Complications of Laparoscopic Hiatal Hernia Repair Complicated by Gastroesophageal Reflux Disease Using the ERAS Protocol

    Osh State University 106 participants Est. completion 2025-08-01
    Other conditions: Hiatal Hernia, Hiatal Hernia With Gastroesophageal Reflux Disease
    View official trial listing →
  • Completed NCT NCT07142486

    Effects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal

    Not yet reported McGill University 4 participants Est. completion 2026-06-19 1 site
    Other conditions: Digestive Health, Gastrointestinal Health
    View official trial listing →
  • Not yet recruiting NCT NCT07144657

    Prospective Study of Frontline Antibiotics Therapy in the Treatment of Early-stage HP-negative Gastric MALT Lymphoma

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2030-12-31 1 site
    Other conditions: MALT Lymphoma of Stomach
    View official trial listing →
  • Completed NCT NCT07149415

    A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55

    Not yet reported Biogen 22 participants Est. completion 2025-10-16 1 site Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Terminated NCT NCT07214662

    A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

    Not yet reported Genentech, Inc. 3 participants Est. completion 2026-06-24 4 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT07223671

    Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

    Not yet reported Bristol-Myers Squibb 30 participants Est. completion 2026-03-19 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT07235748

    Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

    Not yet reported Institut de Recherches Internationales Servier (I.R.I.S.) 28 participants Est. completion 2025-12-23 1 site Stand-alone
    Other conditions: Healthy Adult Participants
    View official trial listing →
  • Completed NCT NCT07259330

    To Determine the Effect of CYP Induction Following Administration of Nirogacestat in Healthy Adult Male Participants

    Not yet reported SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 20 participants Est. completion 2026-03-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07269756

    A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects

    Not yet reported Shandong Suncadia Medicine Co., Ltd. 40 participants Est. completion 2026-03-08 1 site Stand-alone
    Other conditions: Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT07294846

    Drug Interaction Study on Linaprazan Glurate Capsules

    Not yet reported Jiangsu Sinorda Biomedicine Co., Ltd 56 participants Est. completion 2025-12-15 1 site
    Other conditions: Healthy Volunteers, Patients
    View official trial listing →
  • Not yet recruiting NCT NCT07312370

    Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing

    Not yet reported LanZhou University 120 participants Est. completion 2026-12-30 1 site
    Other conditions: Early Gastric Cancer, Gastric Dysplasia, Gastric Neoplasms, Peptic Ulcer With Haemorrhage, Gastric Ulcer
    View official trial listing →
  • Completed NCT NCT07312721

    Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced Gastritis

    Not yet reported Azfar Farogh 752 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Chronic Gastritis, Peptic Ulcer Disease
    View official trial listing →
  • Completed NCT NCT07326904

    Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease

    Not yet reported Universitas Indonesia 145 participants Est. completion 2024-12-13 3 sites
    Other conditions: Gastro Oesophageal Reflux Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07399054

    Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU

    Asian Institute of Gastroenterology, India 50 participants Est. completion 2027-02-28
    Other conditions: Stress Ulcers, Reflux Episodes
    View official trial listing →
  • Not yet recruiting NCT NCT07426042

    Effect of Dexamethasone on CYP Enzyme Activity in Healthy Male Subjects

    Not yet reported Min Kyu Park 12 participants Est. completion 2026-06 Stand-alone
    Other conditions: Drug-Drug Interactions
    View official trial listing →
  • Completed NCT NCT07487142

    Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"

    Not yet reported Beni-Suef University 121 participants Est. completion 2025-12-24 1 site
    Other conditions: H Pylori Infection
    View official trial listing →
  • Completed NCT NCT07563491

    Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

    Not yet reported Muhammad Aamir Latif 824 participants Est. completion 2025-09-30 1 site
    Other conditions: Gastro Esophageal Reflux
    View official trial listing →
  • Not yet recruiting NCT NCT07565441

    Drug-Drug Interactions of JMKX003142 in Healthy Participants

    Not yet reported Jemincare 112 participants Est. completion 2027-02-28 Stand-alone
    Other conditions: ADPKD (Autosomal Dominant Polycystic Kidney Disease)
    View official trial listing →
  • Not yet recruiting NCT NCT07606833

    The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium Enteric-coated Tablets Combined With Bismuth-containing Quadruple Therapy in Eradicating Helicobacter Pylori

    Not yet reported Xuanzhu Biopharmaceutical Co., Ltd. 556 participants Est. completion 2027-03-18 1 site
    Other conditions: HELICOBACTER PYLORI INFECTIONS
    View official trial listing →
  • Not yet recruiting NCT NCT07611162

    Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease

    Not yet reported University of Mons 800 participants Est. completion 2030-05-01 1 site
    Other conditions: Laryngopharyngeal Reflux Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07654049

    Study of Teprenone in the Treatment of Glucocorticoid-Induced Drug-Related Gastrointestinal Injury

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2027-06-01
    Other conditions: Gastrointestinal and Digestive Disorder
    View official trial listing →
  • Not yet recruiting NCT NCT07729293

    Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection

    Not yet reported Gala Servicios Clinicos S.L. 140 participants Est. completion 2028-09-30 1 site Stand-alone
    Other conditions: Helicobacter Pylori Infection, Dyspepsia, Gastrointestinal Adverse Effects
    View official trial listing →
  • Not yet recruiting NCT NCT07746934

    Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

    Not yet reported University of Medicine and Pharmacy at Ho Chi Minh City 600 participants Est. completion 2027-12-27 1 site
    Other conditions: Helicobacter Pylori Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07750587

    Predicting Response and Exposure Changes in Cirrhosis for Effectiveness

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 45 participants Est. completion 2028-12-01
    Other conditions: Liver Cirrhosis
    View official trial listing →
  • Not yet recruiting NCT NCT07772700

    Potassium-competitive Acid Blocker Versus Double Dose Proton Pump Inhibitors in High High-risk Peptic Ulcer Bleeding

    Not yet reported National Cheng-Kung University Hospital 108 participants Est. completion 2027-12-31
    Other conditions: Bleeding
    View official trial listing →
  • Not yet recruiting NCT NCT07790549

    Mirgeal® Gel as Add-on Therapy to Esomeprazole in Adults With Non-Erosive Gastroesophageal Reflux Disease

    Not yet reported Liaquat University of Medical & Health Sciences 140 participants Est. completion 2027-01-29 2 sites
    Other conditions: Non-Erosive Gastroesophageal Reflux Disease (NERD)
    View official trial listing →
  • Completed NCT NCT07823140

    Effects of Kudzu Root (Gegen) on Drug-Metabolizing Enzymes and Blood Clotting in Healthy Volunteers

    Not yet reported Chinese University of Hong Kong 56 participants Est. completion 2023-04-28 1 site Stand-alone
    Other conditions: Herb-drug Interactions
    View official trial listing →
  • Completed NCT NCT07824193

    Drug-drug Interaction Study of Clemizole (EPX-100) in Healthy Participants

    Not yet reported Epygenix 54 participants Est. completion 2025-04-03 1 site Stand-alone
    Other conditions: Drug Drug Interaction
    View official trial listing →
  • Completed NCT NCT07838987

    A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants (MK-4208-001/TERN701-1014)

    Not yet reported Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 196 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Not yet recruiting NCT NCT07850960

    Effect of Omeprazole on Gut Microbiota in Adults With Obesity and GERD

    Not yet reported Federal State Budgetary Scientific Institution 26 participants Est. completion 2026-12-25 1 site Stand-alone
    Other conditions: Obesity & Overweight, Gastroesophageal Reflux Disease
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.